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Type 2 diabetes (T2DM) is a health epidemic that continues to worsen.  A major concern 
is that treatment adherence rates hover around 50%, despite the introduction of new 
medications, treatments, and technology.  Lack of adherence by patients can lead to 
complications like blindness, kidney disease, and amputations.  While there have been 
many studies conducted to evaluate patient factors related to adherence, fewer studies 
have been conducted to evaluate the role of the physician-patient relationship.  The 
purpose of this study was to examine the correlation between the physician-patient 
relationship and patient treatment adherence, and examine the moderators of age, 
education, ethnicity, and income.  Gender was included as a moderator in a secondary 
analysis. Two theories formed the theoretical framework of this study: biopsychosocial 
model and self-efficacy theory.  This quantitative nonexperimental study was completed 
with survey data collected from 92 participants in the United States ages 18 or older who 
were under treatment for T2DM for at least a year, and who had seen their physician at 
least once in the previous year.  Correlational and regression analyses were conducted 
using data from the modified Clinician and Group Survey and the Diabetes Management 
Self-Questionnaire.  The physician-patient relationship predicted treatment adherence, 
and gender moderated the relationship.  These findings suggest the importance of the 
physician-patient relationship as a factor in patient treatment adherence.  This has 
important implications for social change because an understanding of which physician 
factors lead to treatment adherence may help improve patient outcomes, reduce T2DM 
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Chapter 1: Introduction to the Study  
 Introduction 
 Diabetes is a costly and chronic disease.  By 2010, diabetes was the seventh 
leading cause of death in the United States, and costs associated with diabetes were 
estimated to be $245 billion in the United States alone (Centers for Disease Control and 
Prevention [CDC], 2014a, b).  There are provider, patient, and healthcare system factors 
that affect diabetes treatment and adherence.  The present study was on provider factors 
related to adherence to treatment recommendations. 
Treating patients for Type 2 diabetes mellitus (T2DM) can include diet, exercise, 
medications, or a combination.  However, patients are more likely to view medications as 
more effective than diet or exercise (Broadbent, Donkin, & Stroh, 2011).  In spite of this, 
patients do not always adhere to their medications for diabetes.  Evaluating just 
medication adherence, researchers have shown differences in patient medication 
adherence depending on the provider, but not what the reasons for those differences were 
(Sencan, Wertheimer, & Levine, 2011; Sherman, Sekili, Prakash, & Rausch, 2011).   
   Other studies have been conducted to evaluate communication between the 
physician and the patient as well as patient engagement.  Better medication adherence 
was observed when patients were in alignment with their providers with regard to 
communication and they were engaged in managing their disease.  Still, almost half of 
the patients diagnosed with diabetes are not adequately controlled, even though there are 





 Complicating effective adherence to T2DM treatment recommendations are 
demographic and socioeconomic factors, which also were examined in this proposed 
study.  For example, patients with lower income backgrounds are less likely to be 
adherent because of a lack of ability to pay for their medications (García-Pérez, Álvarez, 
Dilla, Gil-Guillén, & Orozco-Beltrán, 2013).  Also, patients who live in neighborhoods 
that are not conducive to living a healthy lifestyle, such as ones where there is food 
insecurity or an environment without places to exercise, or where the patient does not feel 
safe walking around, can impede making healthy lifestyle choices (Powers et al., 2015).  
Education level can also impact treatment adherence.  Patients with lower education 
levels or those who have low health literacy may not understand their disease, why they 
need to be adherent, and what the consequences are of not being adherent (Health and 
Human Services [HHS], 2008).   
 Age of the patient is also a factor in treatment adherence.  For example, older 
patients may have physical limitations that impede their ability to exercise.  They may 
also have difficulty following diet recommendations because they have eaten a certain 
way for a number of years.  Finally, patients’ ethnic background may affect their 
treatment adherence.  It may be challenging for patients to change their diet if they are 
instructed to eat foods that are not familiar to them. 
 The researcher completed this study to examine whether there is a relationship 
between the physician-patient relationship and patient treatment adherence in adult 
patients diagnosed with T2DM.  Four moderator variables were also included in the 





background, problem statement, purpose, and corresponding research questions are 
discussed.  The theoretical framework of the study is also presented, with a more in-depth 
discussion in Chapter 2.  Lastly, the significance of the study is presented, including how 
the results may contribute to social change.  
Background 
Diabetes continues to increase both in the United States and worldwide.  By 2030, 
it is estimated that 552 million people worldwide will have diabetes (Whiting, 
Guariguata, Weil, & Shaw, 2011).  This is due in part to an increasingly obese and older 
population.  Despite being encouraged to diet and exercise when diagnosed with diabetes, 
most patients do not adopt these recommendations (García-Pérez et al., 2013).  Even with 
improvements in technology, medications, and methods to improve treatment adherence, 
adherence levels are still about 50% (García-Pérez et al., 2013).   
There have been many studies investigating patient treatment adherence with 
regard to T2DM.  These include studies on diet, exercise, and medication adherence.  
Overwhelmingly, good patient treatment adherence, whether diet, exercise, medication, 
or a combination leads to better patient outcomes in patients with T2DM.  A nutritious 
diet is another key part of T2DM treatment, both to help lose weight and maintain a 
healthy weight.  Approximately 80-90% of patients diagnosed with T2DM are 
overweight or obese (Vasilescu, 2015).  Exercise can help reduce the chances of being 
diagnosed with T2DM and even reverse it in some patients.  However, it is not always 
easy to find healthcare-based programs and insurance companies will not reimburse them 





 Sencan et al. (2011) and Sherman et al. ( 2011) conducted studies to evaluate 
patient medication adherence as instructed by the providers. There were differences 
found among providers regarding level of patient medication adherence, but the reasons 
for those differences were not determined  These results point to the possibility that 
physician differences including communication style and behaviors may contribute to the 
level of patient treatment adherence (Sherman et al., 2011).   
There are several studies with general patient populations where researchers have 
evaluated the physician-patient relationship including communication, patient 
engagement with the physician (Simmons, Wolever, Bechard, & Snyderman, 2014), and 
shared decision-making (Peek, Drum, & Cooper, 2014).  Better communication, 
engagement, and shared decision-making led to better patient adherence.  The purpose of 
this study was to evaluate several of the physician-patient relationship aspects together, 
including communication, shared-decision making, trust, and respect to help identify if 
there are any aspects that correlate more with improved treatment adherence.   
Problem Statement 
García-Pérez et al. (2013) indicated that only about 50% of patients are adherent.  
Additionally, the incidence of diabetes had almost doubled worldwide among adults, 
from 4.7% in 1980 to 8.5% in 2014, and is now considered a major health epidemic that 
continues to worsen despite adherence interventions (World Health Organization [WHO], 
2016).  Diabetes can lead to other serious complications including cardiovascular disease, 
stroke, kidney disease, blindness, neuropathy, and amputations.  There are also concerns 





treat diabetes have tripled worldwide from 2003 to 2013.  It is estimated that by 2030, 
diabetes costs, including direct and indirect costs, will total $1.7 trillion worldwide 
(WHO, 2016).  Direct costs are those associated with diabetes management, like 
medications or hospitalizations, while indirect costs can be associated with lost wages or 
inability to work due to disability (WHO, 2016). 
Part of the successful management of diabetes includes diet, exercise, and if 
needed, medication.  It also requires a patient to be engaged in their treatment (Simmons, 
et al., 2014).  Patient engagement means that the patient understands and is actively 
engaged in helping to manage his or her health; and performs the behaviors to help reach 
this goal (Simmons et al., 2014).  While there is a lot of research on patient-related 
factors and treatment adherence, patient treatment adherence has not improved.  Diabetes 
incidence has continued to increase, along with complications and costs.  There is, 
however, a lack of research on how the physician-patient relationship relates to patient 
treatment adherence. 
Purpose of the Study 
 The purpose of this quantitative study was to explore the gap in the literature 
regarding the physician-patient relationship and the connection that it may have to 
treatment adherence in patients diagnosed with T2DM.  There are many studies where 
researchers have evaluated patient treatment adherence that focused on patient factors, 
but not health care provider factors or the relationship between the physician and patient 
that might relate to treatment adherence.  Additionally, education, age, ethnicity, and 





treatment adherence.  Sherman et al. (2011) found that medication adherence varied by 
physician, pointing to the effect of physician factors on adherence.  This current study 
fills the gap in the literature by evaluating patient treatment adherence prospectively, by 
having patients’ complete surveys on both treatment adherence and physician factors.  
This relationship along with potential moderators was evaluated to see if there was a 
relationship between level of satisfaction of the relationship with the healthcare provider 
and patients’ treatment adherence. 
Research Questions 
The following five research questions were addressed using the quantitative 
methodology to determine whether there is a relationship between healthcare provider-
patient relationships and patient treatment adherence as measured by scores on the 
physician-patient satisfaction survey and DSMQ. 
RQ1: Among patients (ages 18+) with T2DM, is there a significant relationship 
between treatment adherence as measured by scores on the DSMQ, and the patients’ 
scores on physician-patient satisfaction surveys for patients with T2DM?  
H01: Among patients (ages 18+) with T2DM, there is no significant relationship 
between scores on the DSMQ and scores on physician-patient satisfaction surveys. 
HA1: Among patients (ages 18+) with T2DM, there is a significant relationship 
between scores on the DSMQ and the patients’ scores on physician-patient satisfaction 
surveys. 






H02: There is no moderating effect of age on the relationship between patient 
satisfaction and treatment adherence. 
HA2: There is a moderating effect of age on the relationship between patient 
satisfaction and treatment adherence. 
RQ3: Does level of education moderate the relationship between patient 
satisfaction and treatment adherence? 
H03: There is no moderating effect of level of education on the relationship 
between patient satisfaction and treatment adherence. 
HA3: There is a moderating effect of level of education on the relationship 
between patient satisfaction and treatment adherence. 
RQ4: Does ethnicity moderate the relationship between patient satisfaction and 
treatment adherence? 
H04: There is no moderating effect of ethnicity on the relationship between 
patient satisfaction and treatment adherence. 
HA4: There is a moderating effect of ethnicity on the relationship between patient 
satisfaction and treatment adherence. 
RQ5: Does income moderate the relationship between patient satisfaction and 
treatment adherence? 
H05: There is no moderating effect of income on the relationship between patient 
satisfaction and treatment adherence. 
HA5: There is a moderating effect of income on the relationship between patient 





Theoretical Framework for the Study 
 The theoretical framework of this study included both the biopsychosocial theory 
(BPS) and the theory of self-efficacy.  The BPS theory, introduced by Engel in 1977, 
includes the psychosocial aspects of diseases that are not addressed with the medical 
model.  These include the psychological and social aspects of functioning, which 
contribute to how an individual navigates living with a chronic disease (Sperry, 1988).  
Many healthcare providers are trained in treating patients using the biomedical model, 
and not the BPS model.  Evaluating other factors that may impact treatment adherence 
like the healthcare provider-patient relationship or patients’ socioeconomic status 
incorporates the psychosocial framework of the BPS theory. 
 Patient management of T2DM can be considered by applying the theory of self-
efficacy.  Self-efficacy, also known as personal efficacy, refers to the belief that an 
individual has about his or her ability to accomplish certain goals or tasks (Bandura, 
1977; Lorig and Holman, 2003). Personal efficacy is influenced in four ways: individual 
accomplishments, watching others’ experiences, verbal persuasion, and the individual’s 
own physiological states (Bandura, 1977).   
 T2DM is considered a chronic disease and because it can be long lasting, requires 
that the patient to be an active participant in his or her disease management in order to 
reduce complications (Holman & Lorig, 2004).  Self-efficacy for patients diagnosed and 
being treated for T2DM can include the following four factors.  One is how the patients 
manage treatments prescribed by their providers, associated with verbal persuasion.  





accomplishment.  A third aspect is their physiological state.  Lastly, watching others or 
experiential experience can be associated with belonging to support groups and seeing 
how others manage their chronic disease.  Using both the BPS and the self-efficacy 
theoretical frameworks enabled both individual internal and biopsychosocial factors to be 
evaluated and was appropriate due to the variables in this study.  
Nature of the Study 
This was a quantitative and correlational survey study design.  This approach was 
selected to evaluate a potential relationship between the physician-patient relationship 
and patient treatment adherence.  The predictor variables were scores on the Consumer 
Assessment of Healthcare Providers and Systems (CAHPS®) Clinician and Group 
Survey 2.0, English version (CAHPS) and the outcome variable was treatment adherence 
measured by scores on the Diabetes Self-Management Questionnaire (DSMQ).  The 
hypothesis was that patients who score higher satisfaction and adherence scores on the 
surveys would also report better treatment adherence.    
Multiple regression analyses were used to analyze the data.  To test for 
interactions, moderation analyses were used to examine whether education, age, 
ethnicity, or income moderated the relationship between the “physician-patient 
relationship” predictor variable and the “treatment adherence” dependent variable.  
Demographic data on age, education, gender, income, and race were also collected 
through online surveys from Survata, SurveyMonkey, and paper and pencil surveys from 






A1C: The glycosylated hemoglobin test or A1C is a blood test that measures the 
average blood glucose level of a patient for the previous three months.  A reading of 
5.7% or below indicates normal A1C, while those from 5.8%-6.4% indicate prediabetes.  
Patients with an A1C of 6.5% or higher are diagnosed with having diabetes (National 
Institutes of Health, [NIH] 2014).  
Shared decision-making: Shared decision-making is an approach where the 
patient and the healthcare provider work collaboratively to explore different treatment 
options and decide together what option to choose based on the values and preferences of 
the patient (Agency for Healthcare Research and Quality, 2016a). 
Treatment adherence: Treatment adherence is described as how well a patient 
complies with the treatment regimen prescribed by his or her healthcare provider.  This 
can include following diet, exercise, and medication regimens (García-Pérez et al., 2013). 
Type 2 Diabetes Mellitus (T2DM): T2DM is associated with insulin resistance 
where the pancreas is still producing insulin but the body is not utilizing it properly 
(Centers for Disease Control, 2014a, b).  
Assumptions 
 Several assumptions were made for this study.  It was assumed that the 
respondents would answer the survey questions honestly regarding demographic 
information, treatment, and questions related to the participants’ relationship and 
experience with their providers.  It was also assumed that the participants would answer 





adherence—as measured by DSMQ survey scores and the physician-patient relationship 
as measured by the (CAHPS)—are main variables in the study, it was important for the 
participants to answer accurately and honestly.  Another assumption was that the 
physician has recommended the treatment behaviors to the patient.  These include diet, 
exercise, and adherence to their medication.  Finally, the CAHPS and DSMQ instruments 
used to collect the data were assumed to be valid and reliable. 
Scope and Delimitations 
The participants selected for this study were men and women ages 18 and over, 
diagnosed with T2DM for at least a year.  They must have also been under the care of a 
healthcare provider and have seen this provider at least once in the last 12 months.  The 
patients needed to be receiving treatment for their T2DM.  The treatment would consist 
of diet, exercise, or medications, prescribed individually or in combination.   
 The self-report surveys, written in English, were provided to the participants to 
complete online at SurveyMonkey or with paper and pencil for participants who did not 
have access to the internet.  The data collected from the pencil and paper surveys were 
included with the online data collected from the SurveyMonkey surveys.  Data was also 
collected from a clinic located in Louisiana.  These clinic survey participants had the 
option to fill out paper and pencil surveys or fill the surveys out online.  Paper and pencil 
surveys were offered to the clinic participants because most of their patients were on 
limited cell phone data plans.  Paper and pencil surveys were also offered to participants 
from a clinic in Texas, along with the option to go online.  Other survey participants were 





Association, Survata, and Nextdoor.  These survey participants were directed to access a 
SurveyMonkey link provided by the researcher.   
Limitations 
 There are limitations that needed to be considered for this study, including threats 
to internal and external validity.  One threat to internal validity was the correlational 
design of the study.  Causality and direction of causality cannot be inferred from 
correlational studies and may be affected by other variables that may or may not be 
measured (Field, 2009).  
Regarding external validity, one threat was that the participants may not have 
been representative of the general population.  Only a small percentage of people 
participate in research, and in minority groups, the percentage of people that participate 
are even lower (Moyer, 2009).  Also, according to the United States Census Bureau 
(USBC)  (2015 a, b), approximately 16% of Americans, more likely those who are lower 
income, older, or minority are estimated to not have access to the Internet.  This was an 
important group to access for the study because of the moderator variables and survey 
questions.  Having the option of a paper and pencil survey also helped to address this 
issue.   
Another threat to external validity was that study subjects who did not read or 
write English were unable to participate in the survey.  Since the physician-patient 
relationship was the independent variable in the study and communication is a part of that 
relationship, this also excluded patients who do not read or write English and limited the 





way to know whether the participants were being honest and factual with their responses.  
Some participants may not have felt comfortable rating their provider, especially if the 
rating was a negative one.  Finally, since the paper and pencil surveys were offered only 
to one clinic in Louisiana and one clinic in Texas these results cannot be generalized to 
other populations.  However, using other sources like Facebook, Survata, the Walden 
University’s participant pool, and Nextdoor drew from more diverse populations.  The 
Texas Psychological Association (TPA) also posted an explanation of the study on their 
daily email update along with a link to SurveyMonkey.   
Significance of the Study 
 Current approaches to treating T2DM are not entirely successful, with only about 
half of patients adhering to treatment.  Additionally, the incidence, comorbidities, and 
costs associated with T2DM continue to increase at a rapid pace, which is placing 
economic burdens on both individuals with T2DM and society as a whole.  Diabetes is 
currently the seventh leading cause of death in the United States (CDC, 2014) and is 
expected to be the seventh leading cause of death in the world by 2030 (WHO, 2016). 
    Physician understanding of the patient through a biopsychosocial lens and 
patient engagement is now being recognized as important factors in management of 
T2DM.  The American Diabetes Association (ADA) (2016, 2018) publishes 
recommendations for the treatment of diabetes each year. In 2015, the overriding theme 
was the individualization of treatment for patients with diabetes.  The ADA 
recommendations also included shared-decision making between the patient and health 





likelihood of medication adherence, and patient preferences (Romeo & Abrahamson, 
2015). 
  Patients with low socioeconomic status (SES) backgrounds and limited education 
have two to four times the risk of developing diabetes compared to individuals with 
higher income levels or more education (Torenholt et al., 2015).  Poverty can lead to 
stress over finances, cost of treatment, and also lead to a lack of resources such as 
nutritious food or good housing (Hill, Nielsen, & Fox, 2013).  If physician-patient 
relationship factors can be identified that improve patient treatment adherence, this may 
lead to better treatment adherence in patients with T2DM.  Better T2DM management 
may lead to less diabetes complications, comorbidities, and direct and indirect costs 
associated with diabetes.  Accordingly, there was a need for more studies to examine the 
healthcare provider-patient relationship.    
 Positive social change will occur if patients who are diagnosed with T2DM can 
learn about and are willing to more effectively manage their T2DM.  This in turn should 
reduce healthcare costs by reducing T2DM complications and improving patients’ quality 
of life.  This might also help the physicians feel like they are helping their patients have 
better health outcomes.  Having an increased understanding of these physician factors can 
lead to strategies that can be implemented to enhance patient treatment adherence. 
Summary 
This chapter included a review of Type 2 diabetes mellitus (T2DM) and the 
challenges associated with treating it.  T2DM is a worldwide problem that is continuing 





treatment adherence, there is a lack of studies evaluating the provider-patient 
relationship.  Despite the medical advancements and increased information regarding the 
benefits of diet and exercise, compliance still hovers around 50%.  Recommendations 
from the ADA include individualizing treatment for the patient by taking into account the 
cultural and socioeconomic background of the patient and also including the patient in 
shared decision-making about their treatment plan.   
Also, in this chapter, the purpose of the study was discussed, along with the 
variables related to the physician-patient relationship and treatment adherence.  The 
moderators of age, education, ethnicity, and income, as well as research questions were 
also included.  The theoretical framework of the study, including the BPS model and the 
theory of self-efficacy, were discussed with the rationale behind using these theories as 
the theoretical framework.   
The quantitative nature of the study and the participant qualifiers of age and type 
of diabetes were described.  The rationale for collection of data through SurveyMonkey, 
Survata, and the Louisiana and Texas clinics was explained, along with how the data 
were analyzed using the Statistical Package for the Social Sciences (SPSS).  Definitions 
were listed and assumptions, scope of the study, and limitations were also described.  
Finally, the significance of the study was discussed, including information on the societal 
need for a better understanding of what factors influence patient treatment adherence.  
Chapter 2 includes a review of the current literature on diabetes, the theoretical 












Chapter 2: Literature Review 
Introduction 
This literature review includes an examination of the relationship between 
treatment adherence in patients with T2DM and potential physician factors that may 
affect the adherence. While researchers have examined patient and physician factors, 
there is little research on just the physician factors and the physician-patient relationship 
with regard to T2DM. Since T2DM is an increasing problem both in the United States 
and worldwide, and medication adherence varies, it is imperative to identify physician-
related factors that may be contributing to patient variance in treatment adherence. Poor 
adherence leads to both increased healthcare costs and poor health outcomes.   
This chapter provides an overview of the incidence of T2DM, treatment 
adherence and how it is measured, and physician-patient relationships.  The theoretical 
frameworks of the BPS model and the theory of self-efficacy are also discussed.  Also 
included is the data on medication adherence rates for patients with T2DM including 
improvements in technology to monitor or improve medication adherence in these 
patients.  The increase of medications available to these patients has not improved 
medication adherence either (Strain et al, 2014).  Interventions to improve medication 
adherence may be a more effective approach to improve population health outcomes than 
the treatments themselves (Sabaté & WHO, 2003).  This current research adds to the 
existing literature by addressing the gap in identifying those provider (physician) factors 







 A literature review was conducted by using the Walden University databases 
Academic Search Complete, ProQuest Central, and Science Direct.  Also, PsycINFO was 
searched alone and in combination with all databases selected to ensure the health and 
business databases available on EBSCO were included.  Searches were also conducted 
using Google Scholar. Key words used included: Age, biopsychosocial theory, diabetes 
mellitus, diet, education, ethnicity, exercise, income, medication adherence, physician-
patient relationships, treatment adherence, and Type 2 diabetes.  Peer-reviewed journal 
articles and books were included with an emphasis on current research.  Current articles 
published within the last five years were included in this study, as well as older articles 
that were foundational for the current research.  
Biopsychosocial Model and Theory of Self-Efficacy 
The biopsychosocial (BPS) model was chosen as part of the theoretical framework to 
examine how treatment adherence is affected by various factors, including those that are 
patient, physician, and health care system focused. Despite all the advances made with 
diabetes treatment, there is still less than ideal control among individuals with T2DM. 
This has led to a focus on the psychosocial factors of diabetes instead of just the medical 
aspects (Holt & Kalra, 2013).  
  The BPS model was first proposed by Engel (1977) as a response to the medical 
model of disease that did not include the psychosocial factors that also have an impact on 
disease.  The BPS model is much like von Bertalanffy’s general systems theory where all 





biological, personal, or social (Ravenek et al., 2013; Williams et al., 2000). The BPS 
model is comprehensive and integrative, making it well suited for chronic conditions 
(Sperry, 1988).  The biological aspects of the model include physical and biological 
functioning of the patient, which also encompasses autonomous body functioning outside 
of conscious awareness.  The psychological aspects of the model are how individuals 
view themselves, the outside world, cognitions, behaviors, and motivations.  The social 
part of the model encompasses the individual’s behaviors related to family, friends, 
culture, and institutions (Sperry, 1988).  The BPS model can be used as a framework 
when evaluating the different factors that affect treatment adherence, including the 
healthcare provider relationship with the patient.  Many healthcare providers have been 
trained on the biomedical model but not the BPS model.  This leaves a gap in their ability 
to address the psychosocial aspects of T2DM (Jaini & Lee, 2015).  The biomedical model 
is based on only the biological factors affecting health and excludes the psychological, 
social, or behavioral aspects that may affect how the patient manages his or her health 
(Engel, 1977). 
 Treatment adherence does not take place in a vacuum.  Patients are challenged by 
other factors that make adhering to their treatment plan for chronic diseases much more 
difficult and add to their burden of treatment (BOT).  In a multi-country web-based 
qualitative study of patients with chronic conditions, several BPS factors were found that 
contributed to BOT—managing the medications at home and away, cost of medications, 
financial burden of the T2DM on the patient, social and professional consequences, 





(Tran, Barnes, Montori, Falissard, & Ravaud, 2015).  Patients with diabetes are required 
to make daily self-care decisions, some of which can be complex (Powers et al., 2015).   
 Part of the coordination of treatment for T2DM may also involve diet and 
exercise with or without medication.  In some patients who are obese, just dieting alone 
can help them get to a normal weight and stop them from being diabetic.  Exercising also 
helps patients lose or maintain their weight, as well as better control their diabetes 
(Nazarko, 2010).  The BPS model framework is helpful for identifying how biological, 
psychological, and social factors can affect the ability of a patient to follow diet and 
exercise guidelines when diagnosed with T2DM (Snooks, 2009).   
 The biological aspects of diet include: health, hunger or appetite, satiety, energy, 
genetics, and nutritional needs.  The psychosocial aspects include: appetite, emotions, 
cultural and family background, learned behaviors, media influences, and socioeconomic 
factors (Snooks, 2009).  For example, it may be difficult for patients to find healthy foods 
to eat if they are located in a food desert where access to stores with healthy foods is 
limited (Bader, Purciel, Yousefzadeh, & Neckerman, 2010).  Having limited or low- 
quality foods available would make it difficult for the patient to follow a healthy diet.  
Exercise may be influenced by biopsychosocial factors too.  Socioeconomic status (SES) 
can affect level of exercise in different ethnic groups along with nutritional and 
psychosocial factors (Wang & Chen, 2011).  One reason for less physical activity is that 
residents with low SES may live in neighborhoods where safety is a concern.  Also, these 





issues, time constraints, and lack of energy (Meyer, Castro-Schilo, & Aguilar-Gaxiola, 
2014). 
 The patient’s capacity to juggle all of these factors can become a challenge as 
more of the demands of life are placed on the patient.  This can lead to an imbalance in 
workload and capacity where the patient is unable to manage his or her illness 
effectively, leading to more negative health outcomes (Shippee, Shah, May, Mair, & 
Montori, 2012).  Patients diagnosed with T2DM can spend two hours or more each day 
managing their self-care, which can add to the BOT (Tran et al., 2012).  Patients living 
with T2DM can experience reduced quality of life and increased emotional distress 
because of fluctuations in blood glucose levels and loss of freedom in decision-making.  
For example, a patient diagnosed with diabetes may have to make different food choices 
(Kadirvelu, Sadasivan, & Ng, 2012).  
 Additionally, the burden of managing their disease becomes more of a patient and 
caregiver responsibility than that of the healthcare system.  The patient may be tasked 
with monitoring and managing his or her treatment at home.  If the patient has low health 
literacy, cognitive impairment, or physical limitations, this can present challenges to the 
patient managing their disease (Mair & May, 2014).  The burden of treatment is not 
routinely addressed in patient-clinician clinical encounters. According to Bohlen, 
Scoville, Shippee, May, and Montori (2012), discussions of BOT usually does not 
include any strategies to help solve it.  Tran et al. (2012) constructed a treatment burden 





concluded that this questionnaire could be used to determine treatment strategies to 
improve healthcare outcomes in patients with chronic diseases.  
Theory of Self-Efficacy 
 The biopsychosocial model helps to explain how different factors affect health, 
but it does not explain how the patient can learn to control or self-manage his or her 
chronic disease.  Self-management of disease involves three aspects.  The first is to treat 
the medical aspects of the chronic disease like taking medications.  The second aspect is 
that of finding ways to live a meaningful life by adjusting one’s behaviors to incorporate 
elements of the chronic disease.  The third aspect involves the emotional components of 
adjusting to the chronic disease.  For example, a patient with foot neuropathy from 
diabetes may benefit from exercising in a chair (Corbin & Strauss, 1988).  
 One program that has demonstrated success is the Stanford University Chronic 
Disease Self-Management Program (CDSMP).  In addition to improving symptoms of 
chronic diseases like fatigue and depression, this program has helped patients to foster 
better communication with their physicians (Ory et al., 2013).  This program was based 
on a study of a trial evaluating a community-based self-management program for patients 
with chronic illness (Stanford Patient Education Research Center, 2016).  Learning from 
patients that a sense of control helped in managing their chronic illness led Lorig to the 
theory of self-efficacy (Lorig & Holman, 2003).  This is based on Bandura’s (1977) 
theoretical framework of self-efficacy where personal efficacy comes from four sources, 
the individual’s own successful accomplishments, being verbally persuaded, his or her 





 Taking part in these chronic disease self-management programs helps patients 
with the medical, emotional and lifestyle areas.  Lorig discussed how in addition to the 
medical knowledge that patients are given, having other patients share how they have 
lived with chronic disease or patient knowledge helps these individuals with chronic 
illness model these behaviors, which helps to increase self-efficacy (cited by White, 
2005).  
 In summary, effective diabetes management does not happen in a vacuum, resting 
solely on the patient and medical management.  There are other psychosocial factors that 
can help or hinder diabetes management.  These factors include: the patient’s cultural 
beliefs, religious beliefs, friends and family, health literacy, beliefs about T2DM, peer 
support, and gender.  Incorporating these other psychosocial aspects to personalize the 
treatment plan for the patient may improve diabetes self-management, (Kadirvelu et al., 
2012).    
Type 2 Diabetes Mellitus 
There are two types of diabetes. Type 1 diabetes occurs when the beta cells in the 
pancreas are unable to produce insulin.  Insulin is needed to reduce blood glucose levels 
in the body.  As a result, individuals diagnosed with Type 1 diabetes are insulin 
dependent and must either inject insulin or use an insulin pump.  Type1diabetes in adults 
makes up only 5% of diabetes cases.  Type 2 diabetes mellitus (T2DM) is associated with 
insulin resistance where insulin is still being produced by the beta cells but is not being 
properly utilized by the body.  According to the Centers for Disease Control (2014a, b), 





Diabetes is also a growing health concern worldwide.  The World Health 
Organization (2016), in its global report on diabetes, estimated that the worldwide 
prevalence of diabetes was 8.5% in adults.  In the United States, the overall percentage of 
adults with diabetes has steadily increased over time and was estimated to be 12-14% in 
the overall population in 2011-2012.  This increase compared to 1988-1994 was seen 
across all age groups, income levels, education levels and races, although not uniformly.  
Increased incidence of diabetes may be attributed to the increase in obesity and an aging 
population (Menke, Casagrande, Geiss, & Cowie, 2015).  The World Health Organization 
(2016) estimated that by 2030 diabetes would be the seventh leading cause of death.  In 
the United States, by 2010, diabetes was already the seventh leading cause of death 
(CDC, 2014b).   
Furthermore, T2DM can be harder to diagnose and it can lead to other health 
problems like kidney and cardiovascular disease, diabetic retinopathy, neuropathy, and 
limb amputations (WHO, 2016).  Patients with diabetes have double the risk of dying, 
when compared to patients without diabetes.  One percent of the world’s blindness is 
attributed to diabetic retinopathy and diabetes is considered one of the most common 
causes of kidney failure (WHO, 2016).  
Although patients with diabetes have a higher risk of dying than those without 
diabetes, this is not uniform across all age groups.  Tancredi et al. (2015) conducted a 
study to evaluate the risk of death from cardiovascular disease and other causes in 
patients with T2DM compared to a control group.  They found that there was an 





levels.  However, older patients, 75-years-of-age or more, with A1C of 7.8% or less were 
less likely to die than those in the control group while patients younger than 55 had twice 
the risk of dying than those in the control group.  This is concerning because the 
incidence of T2DM continues to increase in younger adults and adolescents.  When 
diagnosed with T2DM at an earlier age, these individuals are at risk to develop more 
adverse cardiovascular and renal complications, as well as neuropathy, retinopathy, and 
fatty liver disease (Wilmot & Idris, 2014).   
T2DM can be considered a chronic disease.  Unlike acute disease which usually 
can be treated and does not last for long, chronic disease tends to be long-lasting and the 
patient has to take a more active role in the management of his or her disease to reduce 
the chances of the disease worsening over time (Holman & Lorig, 2004).  Since T2DM is 
the most common type of diabetes, it will be the focus of this review. 
Treatment Adherence 
Treatment for patients with T2DM can include behavioral lifestyle changes 
incorporating diet and exercise as well as medication adherence.  When managing 
patients with T2DM, it is important to individualize the treatment plan for the patient.  
While the goal of therapy is to achieve an A1C of ≤6.5%, for some patients a higher A1C 
level may be acceptable based on other comorbidities, length of time from T2DM 
diagnosis, history of hypoglycemia, or advanced age (Garber et al., 2016).  
The A1C test is used for diabetes diagnosis, management, and research.  This test 
provides a three-month snapshot of the patient’s average glucose levels.  The A1C test 





hemoglobin, which is found in red blood cells.  These cells live about three months on 
average.  The higher the test result, and the higher the glucose level over the previous 
three months.  Normal A1C levels are 5.7% or below.  Levels from 5.8% –6.4% indicate 
that the patient is prediabetic, and those 6.5% or higher mean the patient has diabetes 
(NIH, 2014).  The healthcare provider can play an important role in educating the patient 
about their disease, treatment recommendations, and the patient’s own role in managing 
his or her disease (Philiips & Phillips, 2016).  Psychosocial factors like financial 
resources, safety of living environment, and food security can also affect how patients are 
able to manage their disease and treatment plan (Powers et al., 2015). 
Diet 
   One lifestyle behavior, diet, can strongly influence T2DM.  Maintaining a 
healthy, plant-based diet that includes healthy fats to maintain or reduce body weight can 
lead to positive T2DM outcomes (Garber et al., 2016).  A balanced diet can help maintain 
normal blood glucose levels and help decrease insulin resistance.  When blood glucose 
continues to be elevated, like with T2DM, this can lead to other health issues such as 
cardiovascular and kidney disease.  Patients’ belief about the effectiveness of a healthy 
diet can also affect their behavior.  Broadbent, Donkin, and Stroh (2011) conducted a 
study of 157 patients with diabetes, 108 with T2DM, to evaluate their perceptions of 
illness and treatment in diabetes.  The patients ranked medication adherence as more 
important than diet and exercise for diabetes management. 
One way the physician can improve dietary choices and outcomes is to add a 





medical nutrition therapy (MNT) is important because of the high rate, 80-90%, of 
patients with T2DM who are overweight or obese.  Even a weight loss of five to ten 
percent of body weight can lead to better health outcomes (Vasilescu, 2015). 
The type of diet chosen also needs to be considered.  Interestingly, the diet 
recommended by the ADA has been found to be less effective in reducing A1C than the 
Low-Carbohydrate Mediterranean Diet (Pizzorno, 2014).  This is because calories from 
food intake are not all created equal.  Food can change the metabolic state of the body in 
positive (nutrient rich), or negative (high glycemic index foods) way.  More focus should 
be placed on eating nutrient rich foods and less on nutrient poor foods (Pizzorno, 2014).    
Exercise 
   Next to diet, physical exercise that includes both cardiovascular and strength 
training is another important part of T2DM management.  This includes patients who are 
trying to lose weight and patients who are trying to maintain their weight (Garber et. al., 
2016).  Data from studies indicate that T2DM can be prevented or reversed with exercise.  
However, the infrastructure to support lifestyle management of diabetes like exercise is 
not readily available through health care systems like cardiac rehabilitation programs are.  
Also, insurance companies do not provide reimbursement for lifestyle management.  This 
leads to increased reliance by the physician on the use of medications to treat T2DM even 
though lifestyle changes like diet and exercise can reduce or eliminate the need for 
medications (Ades, 2015).  However, more reliance on medication by the physician 
might be due to the patients’ perception that medication is more important than exercise, 





   Exercise has been found to improve glucose control even if the patient does not 
lose weight.  It has also been shown to improve cardiovascular risk factors like 
hypertension (Ross & Janiszewski, 2008).  Exercise guidelines for individuals with 
diabetes have been recommended by both the ADA (2018) and the American College of 
Preventive Medicine (2011).  These guidelines include both aerobic and strength training 
exercises (Hameed, Shereef, & Hussain, 2011).  Current recommendations from the 
American Association of Clinical Endocrinologists and the American College of 
Endocrinology are at least 150 minutes per week of moderate exercise, for example 
walking at 15-20 minutes per mile, along with strength training.  Modifications should be 
considered for patients with diabetes along with other complications like co-morbidities 
or obesity (Garber et al., 2016). 
Medication Adherence 
  Medication adherence can be defined as the extent to which a patient follows his 
or her physician’s recommendations for a medication that he or she has been prescribed.  
Interpreting medication adherence rates can be a challenge because there are several 
different ways of measuring adherence.  There are patient self-reports, and quantitative 
measures like pill bottle monitors or electronic medical record refills, none of which has 
been identified as the gold standard for measuring patients’ medication adherence 
(Blackburn, Swidrovich, & Lemstra, 2013). 
 García-Pérez and colleagues (2013) discussed the differences between the 
definitions of adherence, compliance, and persistence.  Adherence refers to a measure of 





or her prescribed medicines.  This can be assessed directly with electronic health records 
or indirectly by asking the patient.  Compliance is often used interchangeably for 
adherence but does not require that the patient agree to the provider’s recommendations.  
Compliance is a measure of the proportion of doses that were administered to the patient 
over the proportion of doses prescribed, over a certain length of time (García-Pérez et al., 
2013).  Persistence refers to how long the patient continues to take the medication during 
the prescribed length of time. Patients given medication that requires one dose per day 
show better adherence than more than once a day (Donnan, MacDonald, & Morris, 
2002).  
There are also different types of medication non-adherence.  There is primary 
non-adherence where the patient never has the prescription filled, non-persistence where 
the patient starts to take the medication, but then stops taking it and non-compliance 
(poor execution) where the patient takes the medication, but does so improperly 
(Blackburn, Swidrovich, & Lemstra, 2013).  Patients may make the decision to not take 
their medications known as intentional non-adherence, or they may exhibit passive or 
unintentional non-adherence where they forget or are careless about medication 
adherence.  Some patients may be associated with both, although even with unintentional 
non-adherence there may be underlying perceptions about adherence based on patients’ 
medication beliefs, social factors and chronic disease that drive this non-adherence, 
making it not so unintentional after all (Gadkari, & McHorney, 2012). 
 Over the last several years, there have been advancements made in the treatment 





to track medication adherence.  Despite these advances, around half of diabetes patients 
are still not meeting treatment goals. In the ENTRED study (Tiv et al., 2012), a French 
population-based study of 3,367 individuals with T2DM, researchers found that 39% of 
the patients had good adherence, 49% had medium adherence, and 12% had poor 
adherence.  This was despite the fact that these patients had access to good healthcare.   
In a study conducted in a large integrated healthcare system where the patients 
had a pharmacy benefit, which included patients with diabetes, adherence was higher in 
White, male, older patients with higher SES, but lower in ethnic minorities, those with 
lower SES, and those with less education (Rolnick, Pawloski, Hedblom, Asche, & 
Bruzek, 2013).  Other studies have shown similar results. Evaluating medication and 
Medicaid adherence among recipients with chronic diseases, Khanna, Mahabaleshwarkar, 
Basak, Datar, and Banahan (2012), found similar outcomes with White males being more 
adherent than female and Black patients enrolled in a state Medicaid program.  
Differences in medication adherence according to gender have been investigated in other 
studies (Manteuffel et al., 2014).  Unintentional non-adherence by patients also shows 
similar patterns with regard to those who are White, with higher incomes, and more 
education less likely to be non-adherent to medications (Gadkari & McHorney, 2012). 
Strategies to improve medication adherence in T2DM patients have not proven to be 
effective, whether singular approaches are used such as text message reminders, or more 
comprehensive multifaceted approaches (Blackburn et al., 2013).   
While the main focus of this dissertation is on medication adherence, patients who 





Instead they may be told to exercise, diet or do a combination of both diet and exercise to 
see if that improves their A1C levels before starting on any medication (García-Pérez et 
al., 2013).  Additionally, they may be asked to incorporate both medication and lifestyle 
changes into their treatment regimen.  Therefore, lifestyle changes will be included 
within the outcome treatment adherence.   
In summary, even though there have been several different strategies developed, 
to increase medication adherence, 50% of patients with T2DM are still non-adherent.  
This is heightened by the increase in diagnosis of T2DM worldwide.  There is also no 
gold standard for measuring medication adherence.  Some patients, when first diagnosed 
with T2DM, may be asked to make lifestyle changes alone or in combination with a 
medication treatment plan.   
Physician Factors Related to Treatment Adherence 
There are several different factors that affect patients’ adherence to healthcare 
providers’ prescribed treatment plans. These include patient related, health system and 
provider factors, and social factors (American College of Preventative Medicine 
[ACPM], 2011).  Considerable research has been conducted on patient-related factors, 
but there is limited research on how healthcare provider-patient relationships affect 
patient medication adherence.   
In the past, patients placed trust in the relationships with their physicians, but over 
time this has changed as healthcare has turned into a commodity, with many different 
individuals directing physician decision making for their patients and reducing the time 





physicians’ limited time with patients, there is a lack of understanding of what healthcare 
delivery strategies are beneficial for improving medication adherence, which is a serious 
gap in the knowledge base that needs to be addressed (Sherman et al., 2011) 
 One aspect of the physician-patient relationship, poor communication, has been 
cited as a factor in non-adherence (Vermeire, Hearnshaw, Van Royen, Denekens, 2001).  
Another physician factor involves patient engagement.  According to a systematic review 
of patient engagement studies by Simmons et al. (2014), more engaged patients, 
including those with diabetes, had better health outcomes.  In one qualitative study of 
nine patients, Cotugno and colleagues (2015) found that the patients valued a good 
relationship with their practitioners.  This is one where the HCP was empathetic and 
provided education on their disease, meeting the patient at the level they were at in terms 
of understanding what the patients’ educational needs were 
    Patients that are actively involved in the process of making health care decisions 
with their physicians have better medication adherence (Parchman, Zeber, & Palmer, 
2010).  However, this can vary based on the health beliefs and attitudes of both the 
physician and patient.  Improved medication adherence is seen when these two are 
aligned (Christensen et al., 2010).  Good communication and a shared decision-making 
approach with the physician can lead to improved medication adherence.  Therefore, a 
lack of these elements may lead to misunderstandings about the disease or a decision not 
to fully disclose concerns by the patient, leading to medication non-adherence (Guénette 





Miscommunication between the patient and the physician can be a reason for 
medication non-adherence.  In a study conducted by Lapane, Dube, Schneider, and 
Quilliam (2007), the authors found that providers gave only basic instructions on 
medications while patients wanted to know more in-depth information about medications, 
like side effects, duration of use, benefits of medication, and efficacy.  This led to 
decreased medication adherence because of a lack of patient understanding of the need to 
take his or her medication correctly.  Furthermore, according to Lapane and colleagues, 
while a large percentage of physicians believed that their patients were adherent, many 
patients were reluctant to tell their physician that they did not want to take or did not plan 
on purchasing the medication. 
Clinical inertia, defined as the physician’s lack of initiating or escalating 
treatment when the patient’s A1C is not at an optimal level (Ziemer, et. al, 2005) is 
another physician factor contributing to poor diabetes management.  Bailey and Kodack 
(2011) conducted a review on T2DM and patients’ medication adherence.  The 
researchers found that even if physicians were aware of the guidelines on optimal A1C 
levels, the physicians still did not escalate the patient’s treatment plan if they were not at 
optimal levels.  Another study by Strain et al. (2014) evaluated clinical inertia from both 
the patient and physician perspective.  Their findings indicated the physicians had low 
expectations of their patients while the patients did not have a good grasp on the 
importance of managing their diabetes.  Despite the increase in medications to treat 





 Patients find more value in learning more about their disease or medications than 
receiving medication reminders like texts (Cascade, Bharmal, Rosen, & Plummer, 2010).  
More support for the importance of good communications between the HCP and the 
patient came from the results of a study conducted by Bunting, Lee, Knowles, Lee, and 
Allen (2011) using a chronic care management model for diabetes that incorporated 
patient education.  These researchers found that using this model helped reduced cost per 
patient and increased patients’ target A1C levels from 38% to 53%.   
 The quality of physician-patient communications was evaluated in the Diabetes 
Study of Northern California (DISTANCE) to evaluate any associations between 
medication adherence and patient communication ratings with their healthcare providers 
(Ratanawongsa et al., 2013).  This study included 9,377 patients diagnosed with 
hypertension, diabetes, hypercholesterolimia or a combination of these diagnoses.  These 
researchers found that patients who reported lower communication scores had lower 
medication adherence, especially those diagnosed with diabetes.  The opposite was also 
seen, where higher provider scores correlated to better medication adherence.  
 In summary, there are several ways in which physicians may have an impact on 
patient adherence.  Is the physician engaging the patient in his or her treatment plan?  Is 
the physician explaining why the patient has to be on medication and why it is important?  
Does the physician understand the other biopsychosocial issues that the patient faces 
when dealing with his or her diagnosis and treatment?  Does the patient trust the 
physician enough both to explain how he or she feels about taking their medication or not 





the physician have clinical inertia where the patient is not having their medications 
adjusted despite not being controlled adequately?   
Moderators of Treatment Adherence 
        In addition to physician factors that may affect treatment adherence in patients, other 
factors like age, ethnicity, income, and education levels may moderate the association 
between treatment adherence and the physician-patient relationship.  These moderating 
factors are often included in research (MacKinnon, 2011).  Hayes (2013) defined 
moderators as those variables that can have an effect on or moderate the relationship 
between two other variables.  
 Moderators can weaken or strengthen, the relationship between the IV and the  
DV (von Eye & Mun, 2013).  Moderators can also help to identify which individuals  
may have different results (Kraemer, Wilson, Fairburn, & Agras, 2002).  Moderators can  
assist in stratifying responders from non-responders, thereby helping to tailor 
interventions.  Moderators that are associated with the individual, such as age and income 
can help the researcher understand which groups may respond differently, while 
moderators that are associated with treatments would show under which conditions  
intervention effects would be seen (Chmura Kraemer, Kiernan, Essex, & Kupfer, 2008).  
For example, the level of income may potentially weaken the relationship between 
medication adherence and the physician-patient relationship if the patient has lower 
income and cannot afford medications but has a good relationship with the physician.  
Income level can affect the physician-patient relationship in other ways.  As the income 





same health information or treatments that they would to those with higher income levels.  
Also they may not listen or show as much emotion with these lower-income patients  
(Verlinde, De Laender, De Maesschalck, Deveugele, & Willems, 2012). In turn, these 
patients may have less trust for the physician, seek healthcare less often, and present with 
more serious illness when they do seek healthcare (Mascarenhas, et al., 2006). 
Moderators 
Age  
Age and treatment adherence.  Age is a non-modifiable risk factor and is 
included in studies as a sociodemographic factor.  Challenges with treatment adherence, 
whether diet, exercise or medication adherence, when managing T2DM can vary by age.  
There are factors that can be unique to each age group.  Patients who are ages 65 or older, 
who represent 27% of diabetes cases, have eaten a certain way for a number of years and 
it may be challenging for them to follow a more restrictive diet (Hemphill, Stephens, 
Rook, Franks, & Salem, 2013).  According to Phillips and Phillips (2014), approximately 
one-third of this age group do not have teeth, which can also make it difficult to follow a 
healthy diet.   
 Younger adults with T2DM are often managed using diet alone.  This can be 
problematic since a diagnosis of T2DM at a younger age can lead to high-risk 
complications (Benhalima et al., 2011a).  Benhalima and colleagues (2011) also reported 
that some of the issues with this age population include: non-adherence, risk-taking 
behaviors, and lack of long-term planning.  In their observational study of 185 young 





three percent of the participants had A1C levels that were still >7 % even after treatment 
Benhalima et al. (2011b).  Twelve percent of the participants, at presentation, were 
started on a diet alone.  Hernández-Alvarez et al. (2010) reported that in some obese 
patients diagnosed at a younger age (18-25 years-of-age), diet may not be as effective due 
to abnormal mitochondrial proteins and genes that do not function normally leading to 
insulin resistance.  This means that some patients diagnosed at a younger age might not 
lose weight even if they are on a proper diet plan. 
Reasons for exercising can also vary according to age.  Both older and younger 
individuals may exercise for social reasons.  However, older individuals may exercise to 
delay health issues associated with aging while younger individuals may exercise for 
weight management (Allender, Cowburn, & Foster, 2006).  According to 2008-2010 data 
from the Centers for Disease Control (2016), overall, approximately one-third of adults 
do not exercise.  Included in the CDC’s data were exercise statistics. Only 20.8% of 
adults participated in both strength training and aerobic exercise while aerobic physical 
activity decreased with increasing age. Phillips and Phillips (2014) found that patients 
who are older may find it difficult to exercise due to mobility issues, cognitive decline, or 
risk of falling.   
 Even when patients are diagnosed with diabetes, they do not always make the 
decision to exercise although this can vary by age too.  In a study conducted by Morrato, 
Hill, Wyatt, Ghushchyan, and Sullivan (2007), in patients diagnosed with diabetes <40% 
engaged in moderate exercise or more intense exercise.  Younger adults were more likely 





some patients with increasing age.  However, just as with diet, a portion of younger 
adults with T2DM may have abnormally functioning mitochondrial proteins and genes, in 
this case reducing their response to exercise (Hernández-Alvarez et al., 2010).  Again, 
this same patient population may be exercising but not gaining the health benefits to 
improve their diabetes.  The other issue with exercise is the generic recommendations 
made by many physicians to exercise, that are not tailored to the patient and do not 
address the problematic metabolic effects caused by T2DM (O’Hagan, De Vito, & 
Boreham, 2013). 
 Across several studies, older patients tended to be more adherent to their 
medications than those who are younger (Briesacher, Andrade, Fouayzi, & Chan, 2008; 
Feldman et al., 2014; Tiv et al., 2012).  Younger patients were also shown to have higher 
A1C levels than older patients in a study conducted by Daly et al. (2009).  This may 
result from poorer compliance observed in younger patients versus older patients with 
diabetes. 
 The results of the National Health and Nutrition Examination Surveys (NHANES) 
reported by the CDC were that patients diagnosed with diabetes ages 18-39 years had 
poorer glycemic control than those patients who were 40-64 years and even poorer 
control than patients ≥ 65 years (Frieden, 2012).  However, as discussed previously, some 
of these younger patients may have abnormally functioning mitochondrial proteins and 
genes that prevent them from experiencing the benefits of diet and or exercise, even if 
they are being adherent to their medication.  This may make it harder for them to gain 





 In summary, even though diet, exercise, and medications, alone or in combination 
are recommended for treatment of T2DM, there are often challenges to adherence, based 
on the age of the patient.  Older patients may have physical limitations or deeply 
ingrained eating habits, while younger patients may have poor adherence to their 
medications or engage in risky lifestyle behaviors.   
 Age and physician-patient relationship.  There is limited information on how 
age affects the physician-patient relationship. In a study conducted by Peck (2011), the 
author discussed that physicians were more likely to have patient-centered encounters 
with their older than age 65 patients, which led to increased patient satisfaction.  Patient-
centered encounters are ones where the patient works in collaboration, takes an active 
role, and mutually agrees with their physician on healthcare decisions (Asimakopoulou, 
& Scambler, 2013).  
 Older patients may take a more deferential role with their physicians than those 
who are younger, or they may be used to a physician encounter where the physician is 
viewed as the authority.  However deferential behavior on the part of the patient cannot 
always be equated with a positive physician-patient relationship.  One aspect of the 
physician-patient relationship, effective communication, does appear to diminish when 
patients are older.  In a study by Smith (2013), it was found that older patients >65 were 
more likely to be dissatisfied with how the physician communicated with them, 
especially if there were other factors involved like lower income, being uninsured, having 






 One reason why these results might have differed is because Peck (2011) 
collected data from only one multi-physician practice of which two of the physicians 
practiced geriatric medicine. Smith (2013) used data gathered from the Medical 
Expenditure Panel Survey (MEPS), which is a U.S. national survey consisting of data 
collected from a subset of communities.  What is important to note is the aging of 
America.  The U.S. Census Bureau (2015b) reported that by 2060, it is estimated that 
there will be 98.2 million people aged 65 and older and would comprise 25% of the 
population whereas in 2013, people aged 65 and older, made up just 14.1% of the 
population. 
Education Level 
 Education level and treatment adherence.  Treatment adherence can be 
dependent on the education level of the patient.  For example, education level can affect 
dietary choices.  Lack of knowledge about nutrition can make it difficult to understand 
how or why it is important to make healthy food choices.  Overall, higher education level 
and income is associated with better quality diets (Darmon & Drewnowski, 2008).  It can 
be difficult to separate out how much influence education level has on treatment 
adherence versus income level.   
However, in a study assessing diet patterns in 17,062 Black and White 
participants evaluating different factors, including education, Kell, Judd, Pearson, 
Shikany, and Fernández (2015) found that individuals with higher education levels were 





stronger predictor than income level.  Adults with higher education levels were more 
likely to exercise. (Morrato et al., 2007). 
 One way that education level can affect medication adherence is if patients have 
low health literacy.  It is estimated that about one-third of the overall U. S. adult 
population has basic or lower health literacy.  However, in certain groups this number can 
be even higher (Weiss, 2015).  Health literacy is important because it affects how 
individuals understand their disease, take medications, process information, and can 
follow instructions (HHS, 2008).  Patients with low health literacy may also mistakenly 
believe that they are controlling their diabetes and therefore choose not to make changes 
to better control it (Ferguson et al., 2015). 
  Lower education levels can lead to medication non-adherence due to low health 
literacy.  Koprulu, Bader, Hassan, Abduelkarem, and, Mahmood (2014) conducted a 
study of T2DM patients’ adherence to diabetic treatment that included demographic 
factors.  The authors found that patients with limited or no education were more likely to 
be non-adherent to their diabetes medications.  One reason for this is that there are a 
higher percentage of individuals with lower health literacy in those groups with less 
education, especially among individuals who did not graduate from high school. (HHS, 
2008).  Individuals with a secondary education are more than two times more adherent to 
their diabetes medications than those without one (Bakar, Fahrni, & Khan, 2016: Cho & 
Kim, 2014), and this supports other studies with similar results that higher education 





adherence.  Patients with less education may not understand how to make healthy diet 
choices, may be less likely exercise, and less likely to be adherent to their medications. 
 Education level and physician-patient relationship.  Education level can 
impact the type of communication and relationship that patients share with his or her 
physician. For example, Verlinde et al. (2012) discussed how patients with lower levels  
of education may not feel comfortable asking the physician questions or the physician  
may interact with them differently, not allowing them the opportunity to ask questions.   
However, patients who have higher levels of education may feel more comfortable asking 
 their physician questions. 
Ethnicity  
 Ethnicity and treatment adherence.  Following a healthy diet can be one of the 
biggest challenges that a patient with T2DM faces when trying to manage their disease 
and treatment plan.  They can feel like they are being deprived or restricted from eating 
what they are used to eating (Cheng et al., 2016).  This can be further complicated by the 
ethnic backgrounds of the patients. 
  Different groups have certain food preferences, cooking techniques, or beliefs 
about food that may not reflect what has been recommended to them.  Furthermore, 
patients from different cultural backgrounds may not understand what foods constitute 
healthy food choices (Carr, 2012).  There is also a lack of published studies investigating 
ethnic minorities and weight loss interventions even though they are at higher risk for 
obesity and health issues.  Those that have been published were short-term, small sample 





 Even if there is awareness about healthy food choices, food insecurity or cost can 
make it difficult for the individual to purchase healthier foods.  Strings, Ranchod, Laraia, 
and Nuru-Jeter (2016) investigated race and sex differences in the association between 
food insecurity and Type 2 diabetes.  In their study, race was found to moderate the 
relationship between food insecurity and T2DM, in White men and women, and Hispanic 
women, but not African American men and women or Hispanic males. (Strings et al., 
2016). 
 Overall, diabetes self-care varies and one of the components of self-care is 
physical exercise.  Johnson, Ghildayal, Rockwood, and Everson-Rose (2014) reported 
that diabetes self-care varied from 20% of patients with high levels of self-care to 64% 
with moderate and 16% with low self-care.  Physical activity was one of five self-care 
behaviors assessed in their study of diabetes self-care activities by race/ethnicity and 
insulin use.  The highest group with a sufficient amount of physical activity was 
American Pacific Islanders, while the group with the lowest was the Hispanic group.  The 
overall physical activity for all ethnic groups was 63.2%.   
 Adherence to medication and T2DM patients stratified by ethnicity is not a well-
researched subject (Peeters et al., 2011).  In a study of T2DM veterans by Gebregziabher 
et al. (2011), they found that non-Hispanic Blacks had lower medication possession rates 
than non-Hispanic Whites.  According to Osborn et al. (2011), one reason may be lower 
level of health literacy, which is seen more in ethnic and minority populations than 
Whites.  In another study by Kaplan, Billimek, Sorkin, Ngo-Metzger, and Greenfield 





of disease state mastery erased any ethnic differences in glycemic control.  Furthermore, 
according to Signorello et al. (2007), differences in diabetes prevalence between Blacks 
and Whites may be due more to other factors than race.   
 African American patients with T2DM continue to have higher mean A1C levels 
than patients who are White (Hausmann & Sevick, 2010).  However, a longitudinal study 
of T2DM veterans by Egede et al. (2013) found that Blacks had lower mortality rates 
compared to Whites, Hispanics, and other races.  One reason for this, according to 
Conway et al. (2015), is that Blacks have reduced mortality from respiratory and 
ischemic disease compared to Whites.  Lower medication adherence has also been seen in 
Asian and Pacific Islanders, compared to Whites (Juarez, Tan, Davis, & Mau, 2014). 
 In summary, there is not a lot of information on diet, exercise, and medication 
treatment adherence when stratified by ethnicity and T2DM.  What is known is that 
minority groups tend be at higher risk than Whites for obesity and health issues.  Also, 
while diet recommendations are often given to patients with T2DM, they are not tailored 
to their ethnic background.  This leads to difficulty understanding what foods are healthy 
or what traditional foods can be made healthy, based on the ethnic background of the 
patient. 
 Ethnicity and physician-patient relationships.  Physicians can vary in their 
approach to patients depending on their cultural or ethnic background.  It is important 
that practitioners recognize the role that ethnicity and culture play when treating patients 
and to understand their impact on the treatment plan (Hickling, 2012). In a study using 





were less communicative and dominated the conversations more with African American 
patients than with their White patients (Johnson, Roter, Powe, & Cooper, 2004).  Another 
study by Lepièce, Reynaert, van Meerbeeck, and Lorant, (2014) was conducted to 
evaluate physicians by giving the physicians two different scenarios.  One group was 
given a non-minority patient case study and the other group a case study of a minority 
patient.  Minority patients were prescribed more medications and had less time devoted to 
their other non-medical issues like social and relational history.  
 The physician-patient relationship is also affected by poor communication due to 
a tendency to approach all patients in the same way despite the patient’s different cultural 
backgrounds (Mott-Coles, 2014).  Physicians can stereotype patients, not understanding 
the cultural beliefs and mores of patients from other cultures, leading to 
miscommunication and poorer health outcomes.  These disparities are seen across 
different health conditions including cancer, cardiovascular disease, and pain 
management (King et al., 2008).  Ethnicity can also influence shared decision-making 
and trust (Peek et al., 2013).  In summary, differences in ethnicity can affect the 
physician-patient relationship because of a lack of understanding of cultural backgrounds 
and poor communication on the part of both the physician and the patient.  This can lead 
to stereotyping by the physician of the patient and a lack of trust in the physician by the 
patient. 
Income 
 Income level and treatment adherence.  Income level can affect treatment 





depending on their income level.  Income can affect diet choices in different ways.  
People with lower incomes may not have the resources like transportation to drive to 
supermarkets with higher quality food choices.  They may choose lower quality foods 
based on price and convenience (Darmon & Drewnowski, 2008).  Finding nutritious food 
in their neighborhood may be difficult and this is seen more in lower-income 
neighborhoods.   
 Another issue can be neighborhood safety.  In some cases, residents of low-
income neighborhoods may choose not to use stores in high crime areas, instead 
travelling further away.  This can lead to the local stores lacking the revenue to carry 
healthier foods (Bader et al., 2010), or the residents may reside in a food desert.  Food 
desert is a term used to describe areas where it is difficult to get nutritious and affordable 
food (Karpyn, Young, & Weiss, 2012).  Neighborhood aesthetics, for example, food 
insecurity affects diabetes self-care behaviors including diet (Smalls, Gregory, Zoller, & 
Egede, 2015).  For those with higher incomes, they are more likely to choose healthier 
foods (Darmon & Drewnowski, 2008).  Therefore, it may be easier for those with higher 
incomes to live in neighborhoods where healthier foods are more prevalent.  
  Just as there can be lack of nutritious affordable foods in lower-income 
neighborhoods, there can also be a lack of places to exercise or concerns with safety if 
one were to go outside in lower-income neighborhoods.  Chan (2016) reported that low-
income neighborhoods are much more likely to lack recreational facilities.  Even if they 





concerned about the safety of the neighborhood.  This can lead to less outside physical 
activity.    
 Evaluating the variables of income and medication adherence is not without 
challenges (Lyles et al., 2016).  Issues with data can arise from individuals refusing to 
report their income.  Older individuals may report less income because they are retired 
and income can be affected by expenditures that can vary from one individual to the next.  
Self-reporting of medication adherence can be skewed by individuals who over-report.  
Considering these variables, there have been some studies where income and adherence 
have been evaluated. 
 A study of non-Hispanic Whites, Vietnamese, and Mexican-American patients 
with T2DM was conducted where the researchers evaluated financial pressures and 
adherence.  Low annual incomes and perceived financial burden led to non-adherence 
that was cost related, especially among the Mexican-American participants (Ngo-
Metzger, Sorkin, Billimek, Greenfield, & Kaplan, 2012).  While attempts have been 
made to treat T2DM, evaluating poverty and how it contributes to diabetes has not been 
addressed (Chaufan, Davis, & Constantino, 2011).  However, another study by Billimek 
and August (2014) evaluating Mexican-American patients with T2DM was conducted to 
drill down further into medication adherence.  The authors found that individual-level 
socioeconomic status was significantly associated with medication non-adherence that 
was cost related, but that neighborhood deprivation was significantly associated with the 





 Medication beliefs can include those about potential side effects or effectiveness.  
This may cause the patients to not take their medications correctly or to discontinue them, 
even if cost is not an issue. (Billimek & August, 2014).  Therefore, while lower 
socioeconomic background can have a negative impact on medication adherence, income 
level and cost of medication are not the only factors to consider.  Reducing costs of 
medications, if the patient does not believe that the medication is effective or will cause 
undue side effects, will not improve adherence (Billimek & August, 2014).  The study 
authors helped to expose the need for a better understanding of the contributing factors to 
medication non-adherence.  In summary, income level can have an impact on where 
people reside, the safety of their neighborhood, access to exercise facilities, 
transportation, and their ability to purchase healthy foods.  This can affect diet, exercise, 
and medication adherence.  
 Income and physician-patient relationship.  Physicians can act differently 
towards lower-income patients. Physicians are less likely to involve these patients in 
healthcare decisions, provide them with less education and show less affect.  The patients 
are also less likely to ask questions (Willems, De Maesschalck, Deveugele, Derese, & De 
Maeseneer, 2005).  One aspect of the physician-patient relationship, trust, can vary 
depending on the income level of the patient.  Those with lower-income levels typically 
have more social distance from the physician and this can lead to a lack of trust, where 
the physician does not think that the patient will adhere to medication regimens; and 





 Individuals who live in poverty are less likely to seek medical care and more 
likely to have chronic diseases.  These patients can feel stigmatized, less respected, and 
judged by their physicians.  In Loignon et al.’s (2010) study on physicians’ social 
competence in the provision of care to persons living in poverty, they find that physicians 
can have a negative attitude with these patients.  
Conclusion 
 This study was conducted to examine the relationship between treatment 
adherence in patients with T2DM and potential physician factors that may affect their 
adherence.  The review of literature included;  search information, the state of T2DM and 
treatment adherence issues.  Also discussed were the theoretical model of BPS and the 
self-efficacy theory, as well as, information on A1C, treatment adherence, and physician 
factors concerning patients with T2DM.  Moderators of education level, age, ethnicity, 
and income were reviewed in the context of the independent (physician-patient 
relationship) and dependent (treatment adherence) variables. 
 There were some common themes found in the literature review.  One was the 
challenge of having differences in measurements or type of measurements for medication 
adherence.  Even the language could vary, with it being defined in some studies as 
medication adherence as compliance or persistence.  There were also different types of 
measures too.  Some studies included patients who self-reported while others utilized 
EMR or MPR, for example.  Various studies had different ways of defining what 
medication adherence involved and varied cut-off points.  Even with these differences, 





factors that will improve T2DM patients’ medication adherence.  A second common 
theme was the need for education that was tailored to the patient.  Over and over in study 
conclusion sections, recommendations were made for the physician to understand their 
patients and their cultural and socioeconomic backgrounds, when giving education about 
T2DM, diet, exercise, and medication.   
 Not all patients newly diagnosed with T2DM are given medication. Some are 
given diet and exercise recommendations to follow.  Following diet recommendations is 
a challenge for some patients if they live in food deserts where access to nutritious food is 
limited or if they cannot afford to eat nutritiously.  Even age can be a factor if the patient 
is older and used to eating a certain way for many years.  Exercising can be challenging 
for patients in lower socioeconomic neighborhoods due to safety issues or lack of 
transportation and local facilities.  The present study was conducted to evaluate these 
sociodemographic variables along with physician communication to try and identify the 
most important drivers of treatment adherence. 
 The American Diabetes Association (ADA) publishes recommendations for the 
treatment of diabetes each year.  In 2015, the overriding theme was the individualization 
of treatment for patients with diabetes.  The ADA recommendations also included 
shared-decision making between the patient and physician, and understanding by the 
physician of the patient’s ethnicity, comorbid conditions, likelihood of medication 
adherence and patient preferences (Romeo & Abrahamson, 2015).  It is up to the 
physician to not only ensure that the patient understands his or her disease and the 





life.  This can only happen with good communications, trust, and respect between the 
physician and patient.  
 In conclusion, improving outcomes in T2DM patients may be helped along by a 
strong physician-patient relationship based on trust, respect, shared decision-making, and 
the patient feeling that he or she has been heard.  Also, the physician should consider 
providing an environment where patients feel comfortable sharing their concerns or 
questions about their T2DM.  Individualizing treatment for a patient, by taking a more 
holistic approach, is becoming more recognized as something that should be considered 
for better health outcomes.  In Chapter 3, the research design, rationale for the study, 
methodology, ethical issues, and threats to validity are discussed.  Also included are the 







Chapter 3: Research Method 
Introduction 
This chapter covers the research design used to examine the potential relationship 
between physician factors and treatment medication adherence, measured using DSMQ 
scores.  This section includes a description of the study’s setting, sample participants, 
procedures, instrumentation, data analysis, and ethical considerations.  Moderating 
factors that may affect the healthcare provider-patient relationship are also discussed, 
such as patients’ education, age, ethnicity, and income level.  
Purpose of the Study 
The purpose of this study was to identify potential physician factors that relate to 
treatment adherence in patients diagnosed with T2DM. Interventions to improve 
medication adherence might be a more effective approach to improve population health 
outcomes than the treatments themselves (Sabaté & WHO, 2003).  This study adds to the 
literature by helping to identify these physician factors that may lead to a better 
understanding of what factors affect patient treatment adherence and in turn lead to 
solutions to help contribute to better patient health outcomes and reduced healthcare 
costs. 
Research Design and Rationale 
This study was quantitative and correlational in design.  The quantitative 
methodology was used to assess whether different factors associated with the physician-
patient relationship showed a significant relationship with DSMQ scores in T2DM.  Data 





addressing level of satisfaction of their physician based on questions from the CAHPS 
Clinician and Group Survey, as well as supplemental items from the CAHPS Adult 
Surveys.  There were some minor changes made to the survey that are discussed in the 
instrumentation section.  The second survey, the DSMQ, was included to capture 
treatment adherence questions (see Appendix A).   
A correlational approach was determined based on the potential relationship 
between physician factors and patient treatment adherence.  For this study, scores on the 
surveys were the predictor variable and self-reported measures from the DSMQ was the 
outcome variable.  The hypothesis was that patients who gave their physicians higher 
scores on provider care would have seen improvements in treatment adherence over at 
least a year or more.  The DSMQ survey was used to identify types of treatment that the 
patient had received related to diet, exercise, medication, or a combination of these 
treatments for their T2DM.   
The following five research questions were addressed using the quantitative 
methodology to determine if there was a relationship between physician-patient 
relationships and patient treatment adherence as measured by scores on the DSMQ: 
RQ1: Among patients (ages 18+) with T2DM, is there a significant relationship 
between treatment adherence as measured by scores on the DSMQ, and the patients’ 
scores on physician-patient satisfaction surveys for patients with T2DM?  
H01: Among patients (ages 18+) with T2DM, there is no significant relationship 





HA1: Among patients (ages 18+) with T2DM, there is a significant relationship 
between scores on the DSMQ and the patients’ scores on physician-patient satisfaction 
surveys. 
RQ2:  Does age moderate the relationship between patient satisfaction scores and 
treatment adherence? 
H02: There is no moderating effect of age on the relationship between patient 
satisfaction and treatment adherence. 
HA2: There is a moderating effect of age on the relationship between patient 
satisfaction and treatment adherence. 
RQ3: Does level of education moderate the relationship between patient 
satisfaction and treatment adherence? 
H03: There is no moderating effect of level of education on the relationship 
between patient satisfaction and treatment adherence. 
HA3: There is a moderating effect of level of education on the relationship 
between patient satisfaction and treatment adherence. 
RQ4: Does ethnicity moderate the relationship between patient satisfaction and 
treatment adherence? 
H04: There is no moderating effect of ethnicity on the relationship between 
patient satisfaction and treatment adherence. 
HA4: There is a moderating effect of ethnicity on the relationship between patient 





RQ5: Does income moderate the relationship between patient satisfaction and 
treatment adherence? 
H05: There is no moderating effect of income on the relationship between patient 
satisfaction and treatment adherence. 
HA5: There is a moderating effect of income on the relationship between patient 
satisfaction and treatment adherence. 
A multiple regression analysis was conducted to assess the moderator variables of 
education, age, income and ethnicity.  Much of the published literature is on either the 
patient factors or on the patient and physician-related factors associated with T2DM, but 
there is a lack of studies on factors with just the physician-patient relationship and 
medication adherence.  An online survey approach along with paper-and-pencil surveys 
was planned to efficiently collect the data in a timely manner.  This also helped to 
broaden the pool of participants geographically to improve generalizability of the 
findings.  There were only two clinics where data was collected, thus these results cannot 
be generalized to other clinics or other parts of the country.  Also, only English-speaking 
participants were recruited, which eliminated participants that spoke other languages.  
The online surveys were captured from different parts of the country. 
Methodology 
Population  
 The participant inclusion criteria for this study consisted of male and female 
patients who had been diagnosed with T2DM, ages 18-75+ and who had been in 





treatment for less than 12 months, were under the age of 18, or could not read or write 
English.  Flyers were provided to recruit participants, with contact person information for 
the paper-and-pencil participants or website information for the online participants. 
 Sampling and Sampling Procedures 
Effect size was determined by examining the literature on this study’s topic.  It is 
important to report effect size because it indicates the magnitude of the difference 
between groups (Sullivan, & Feinn, 2012).  Haskard-Zolnierek and Dimateo (2009) 
conducted a meta-analysis evaluating studies on physician communication and patient 
treatment adherence and found an overall effect size of r = .19 in 106 studies that had 
evaluations of the communication.  This is considered a small effect size, but in line with 
other studies or better.  The effect sizes in these studies were measured using a Pearson, 
point-biserial, or a Phi coefficient.  For studies included in the meta-analysis where an 
effect size was not reported, the authors calculated the Phi coefficient.  For purposes of 
this study, an effect size of .15 was chosen, as this is considered a medium effect size by 
Cohen (1992). 
To determine sample size, an estimated effect size and power needed to be 
calculated (Sullivan & Feinn, 2012).  Power is related to the strength of a study to detect 
a difference, if there is really a difference.  The more the power is increased in a study, 
the more likely that an effect will be correctly detected.  The higher the power, the less of 
a chance of a Type II error, defined as 1-B (Sullivan & Feinn, 2012).   
To calculate the number of participants, the G*Power calculator (Faul, Erdfelder, 





regressions.  Having determined an effect size of .15, a statistical power of .80, five-
predictor variables, (CAHPS scores, education, age, ethnicity, and income) and a 
probability level of .05, the minimum sample calculated was 92.  The incidence of 
diabetes in the United States adult population is 9% and T2DM accounts for 90-95% of 
those cases Centers for Disease Control [CDC], 2014b).  This means that between 8.1–
8.55% of the adult population currently has T2DM diabetes.  Overall, according to the 
ADA (2016), there are 29.1 million Americans who have diabetes, but only 21.0 million 
have been diagnosed. (ADA, 2016).  Based on the American Diabetes Association’s 
(2016) estimate of 21.0 million patients diagnosed with diabetes, if 95% have T2DM, 
then this segment of the population equals 19.95 million individuals. 
A minimum sample of 92 participants was needed for a confidence level of 95%, 
power of 80% and a p (degree of variability) = 0.05.  To account for subjects who may 
not have completely filled out the surveys, an extra 30% of participants would have 
needed to be recruited.  There were very few respondents for this study who did not fill 
out the surveys completely and there were very few survey questions left unanswered.  
Therefore, the final count of 92 participants was sufficient and additional participants 
were not recruited. 
Participants 
Participants, ages 18 and older, were recruited using a convenience sample of 
individuals diagnosed with T2DM and who had been treated for at least 12 months.  The 
surveys were available to complete on SurveyMonkey, which is an online survey 





Data collected through SurveyMonkey Audience can be integrated into SPSS.  Surveys 
can be completed via mobile, the internet, and social media.  There are millions of 
potential participants.  SurveyMonkey also offers the option to HIPAA-enable the 
account if there is a need to do so, offering enhanced privacy and security 
(SurveyMonkey, 2016b).  In addition to SurveyMonkey Audience, participants were 
recruited from two clinics, one in Louisiana and one in Texas.  Paper-and-pencil surveys 
were available for participants that were unable to access the Internet.  This ensured that 
both participants with access to the Internet and those without access to the Internet were 
included.  Survata, an online participant recruitment site, was also used.  Survata 
conducts research with surveys (Survata, 2017), and was able to access participants who 
fit the criteria for this study.  The online SurveyMonkey survey questions were entered 
into the Survata system so that the online participants were all accessing the same online 
survey.  The results were downloaded from Survata into SPSS.  
Data Collection 
  Data Collection occurred through social media, and two clinics, one in Louisiana 
and one in Texas.  The clinic in Louisiana is a nonprofit group that works with patients to 
help educate them on managing their diabetes by offering monthly classes on a variety of 
health-related topics and conducting group exercise activities.  Some of the health-related 
topics include those on nutrition, behavior, foot health, and glucose meter checks.  The 
Louisiana clinic staff agreed to participate in this study, and their patients vary in age 
from young adults to the elderly and many of them do not have access to the Internet.  





with diabetes.  Some of these adult patients agreed to participate in this study, and they 
preferred paper-and-pencil surveys.  Recruiting individuals from different sites helped 
ensure a greater cross-section of participants.  The goal was to have participants from 
different age groups, ethnicities, income levels, and educational backgrounds to better 
detect any changes in the study variables.  
Participants were recruited by posting flyers, from social media networks and 
Walden University.  A paragraph outlining the study with a link to SurveyMonkey was 
listed on the social media sites and the TPA website. Recruiting individuals from 
Facebook, Survata, Nextdoor, and the Walden Participant Pool helped ensure a greater 
cross-section of participants.  The invitation to participate for Facebook, Nextdoor, and 
the Walden Participant Pool can be found in Appendix B.  Data from the paper-and-
pencil surveys were entered by hand into SPSS and included in the online dataset.  
  Included with both the online surveys and the paper-and-pencil surveys was a 
cover page with a section on informed consent, an explanation of the study, and 
information letting the study participant know their participation was voluntary and they 
could decide not to be a part of the study at any time.  Informed consent forms were 
obtained from all participants.  Demographic information on age, gender, education level, 
race, and income were captured from the CAHPS survey questions 42-47.  
  Some additional questions were added to the survey. One question was added on 
whether other individuals help in the management of the participant’s T2DM and a 
follow-up question on how helpful these other individuals were.  An income question 





household income?”  This question includes seven different ranges of income from <$24, 
999 to >$100,000 (SurveyMonkey, 2016b).  Lastly, an additional question was added on 
where the participant heard about the survey.  Data on treatment adherence, the outcome 
variable, were captured by the questions on the DSMQ.   
Instrumentation 
The CAHPS version is a measure of patient satisfaction of his or her healthcare 
provider.  The CAHPS surveys are part of the CAHPS program that is overseen and 
funded by the Agency for Healthcare Research and Quality [AHRQ] (2016b).  Several 
public and private organizations have partnered with CAHPS to oversee and use these 
surveys.  This has helped to provide a unifying thread for the different parts of the overall 
healthcare system (Milleson, & Macri, 2012).  Permission is not required to use the 
CAHPS surveys or the supplemental items for the surveys (AHRQ, n.d.).  The CAHPS® 
Survey 2.0 includes 34 core questions with the ability to add in other supplemental 
questions including those on chronic conditions, provider communications, cultural 
competence, health improvement, health literacy, prescriptions, and shared decision 
making. Questions from the CAHPS® Clinician and Group Surveys Supplemental Items 
for the Adult Surveys 2.0 also were included. These supplemental items included 
questions on the topics of cultural competence, health literacy, shared-decision making, 
and communication with providers (AHRQ, 2016b).  
The CAHPS Clinician and Group Surveys include four measures: information on 
the provider, care from the provider, questions about office staff behaviors, and 





include: yes/no, global rating of 0-10, how often or other 4-point response scale, and 3-
point response scale (AHRQ, 2016b).  The survey questions used in this study only 
included information on the provider, care from the provider, and demographic questions, 
along with some of the corresponding supplemental questions. 
The addition of the supplemental questions to the survey questions resulted in 36 
questions used to measure the physician-patient relationship.  These CAHPS questions 
included the domains of: (1) how well the provider communicated with the patient, (2) 
patient rating of the provider, (3) cultural competence of the provider and being polite 
and considerate, (3) rating of patient trust in the provider, (4) health literacy, (5) health 
improvement, (6) patient centered home, and (7) shared decision making (AHRQ, n.d).  
 Composite scores can be assessed from domains one and three. The overall score from 
the 36 questions was used to address Research Question 1.  The CAHPS survey 
demographic information was used to address the moderator variables in Research 
Questions 2-5.  These moderator variables were age, education, income, and race.  The 
researcher also included a question on other individuals in the physician’s office that 
assisted with the participant’s diabetes care and a question on how the participant heard 
about the survey.   
Physician-Patient Relationship 
  The physician-patient relationship measures was captured from questions on the 
CAHPS survey.  There were several questions from both the main and supplemental 
surveys.  These questions included information on the provider’s behavior towards the 





physician-patient relationship plays an important part in the treatment of patients.  
Components that make up this relationship include communication, level of trust between 
the provider and patient, active listening, and level of shared decision-making between 
the provider and patient on treatment (Lipkin, Putnam, & Lazare, 1995).  These questions 
were evaluated both as one overall score and as composite scores. 
Sometimes the physician will have other staff work with the patients after they 
have been diagnosed with T2DM.  Therefore, question #39 was included in the CAHPS 
survey to capture any other health care providers or staff.  Question #40 is a rating scale 
on how helpful the participant found this or these individual(s).  Other healthcare 
providers include physician assistants and nurse practitioners that prescribe treatment 
regimens to patients diagnosed with T2DM (Centers for Medicare and Medicaid Services 
[CMS], 2006).  Other staff and allied health professionals may include nurses, 
pharmacists, diabetes educator, health coach, or dietician.  Allied health professionals are 
individuals who may interact with patients that are not nurses, pharmacy, or medical 
personnel.  They may be involved in the management of patients with chronic diseases 
like diabetes (Association of Schools of Allied Health Professionals [ASAHP], 2017).  
Moderator Variables 
The moderator variables of education, age, and ethnicity were addressed from 
questions in the CAHPS survey.  Income level, the fourth moderator variable, was also 
added to the survey.  The supplemental questions followed much the same format as the 
core survey ones.  Included were questions answered: Yes or No, Never, Sometimes, 





and No or Not At All, A Little, Some or A Lot (AHRQ, 2016b).  The moderating 
variables of age, education, ethnicity, and income are discussed next. 
 Age.  Age was captured by question #42 from the CAHPS survey.  This question 
has a box where the participant filled in his or her age. 
 Education.  Education level was captured by question #44 in the CAHPS survey  
This survey question was stratified into six categories from completing up to an 8th grade 
education or less to having completed a four-year college degree or more.   
 Ethnicity.  Ethnicity was captured by questions #45 and #46 in the CAHPS 
survey.  Question #45 asked whether the participant was Hispanic or Latino and was 
answered yes or no.  Question #46 asked the race of the participant.  There were six 
possible answers including the reply “other.”  The participant checked one or more of the 
answers. 
 Income.  Income was captured by question #47 in the CAHPS survey. Income 
level choices varied from <$24,999 to >$100,000. 
The psychometric properties of the CAHPS survey were assessed using both a 
cognitive and a psychometric approach.  Cognitive testing allows for evaluation of how 
well respondents comprehend and answer the questions, helps evaluate response choice 
adequacy, and helps with optimal word selection for the surveys.  Field-testing was done 
for measuring reliability and validity.  The goal of this dual approach was to ensure the 
best survey possible (AHRQ, n.d.). 
   The reliability of the CAHPS® Clinician and Group Survey is estimated to be at 





group of providers (AHRQ, 2016b).  The CAHPS surveys are the most often used 
surveys to evaluate consumer experience with health plans and providers in the 
ambulatory setting.  The survey questions are grouped into five composites to make it 
easier for patients to understand.  Reliability of the CAHPS ® 2.0 survey is high (.70) and 
internal consistency ranged from a high of Cronbach’s alpha ≥.75 to a low of .58 
depending on the composite selected (Hargraves, Hays, & Cleary, 2003).  There are also 
psychometric data available on the CAHPS® supplemental surveys.  For example, the 
cultural competence supplemental item set has been evaluated and the internal reliability 
ranged from 0.58 to 0.92, and a confirmatory factor analysis that supported the validity of 
the item set (Weech-Maldonado et al., 2012).  
The Agency for Healthcare Research and Quality (2016b)  has stringent 
requirements surrounding the use of the surveys.  Questions can be added to the survey, 
but none of the core questions can be modified or removed because of the AHRQ goal of 
standardization. If questions are modified, the survey cannot be referred to as a CAHPS® 
survey. This study used questions from both the CAHPS Survey and the supplemental 
surveys, along with demographic questions.  
Diet, Exercise, and Medication Adherence 
 The DSMQ measures self-care activities for the previous eight weeks.  The 
DSMQ was designed to address a gap seen with other diabetes self-management 
questionnaires that are unable to explain changes in A1C levels effectively (Schmitt et 
al., 2013).  There are 16 questions with four response choices from “Applies to me very 





that are formulated positively and nine that are formulated negatively.  When scoring, the 
negative questions are reversed to indicate increased self-care for when the item values 
are higher.  There are four subscales:  Glucose Management, Dietary Control, Physical 
Activity, and Health-Care Use. Question 16 is included in the overall sum score but is not 
a part of the subscales (Schmitt, et al., 2013). 
The DSMQ was used to capture data for the outcome treatment adherence 
variables of diet, exercise, and medication adherence (see Appendix A).  The questions 
under the subscale dietary control measured diet adherence.  The questions under the 
physical activity subscale measured physical activity, and medication adherence was 
measured with the glucose management scale.  The DSMQ consists of 16 questions 
recorded in a four-point Likert scale (3=applies to me very much, 2=applies to me to a 
considerable degree, 3=applies to me to some degree, 4=does not apply to me).  Some of 
the questions require reverse scoring and five of the questions have an additional choice, 
for example, blood sugar measurement is not required as a part of my treatment.  The 
DSMQ can also be divided into four subscales that measure (a) dietary control, (b) 
glucose management, (c) physical activity, and (d) physician contact. The overall DSMQ 
score was used to address Research Questions 1-5. 
 To evaluate psychometric properties, the DSMQ was compared to an established 
scale, the Summary of Diabetes Self-Care Activities Measure (SDSCA) in 261 patients 
with either Type 1 or Type 2 diabetes.  Significant convergent correlations of the DSMQ 
subscales were seen with the SDSCA parallel scales.  However, correlations with A1C 





Internal consistency of the DSMQ was good with an overall Cronbach’s alpha of 0.84.  
The subscales were also good and ranged from 0.77 to 0.60.  According to Schmitt et al. 
(2013), the DSMQ is a reliable and valid test to assess diabetes self-care management 
when evaluating glycemic control.   
Data Analysis 
 Data analyses were conducted using SPSS version 24.  Survey responses from 
both the online surveys and the paper-and-pencil surveys were collected and checked to 
ensure that they had been filled out completely.  Any incomplete surveys filled out by 
participants were addressed by using the SPSS pairwise missing values procedure.  This 
procedure allows for the inclusion of the subject’s other responses, instead of completely 
removing the subject from the analysis.  George and Mallery (2016) recommended that if 
there is more than 15% of the data missing, whether from the individual subject, or a 
variable, that it be dropped from the analysis. 
 Prior to data analysis, a test of multicollinearity was performed.  Multicollinearity 
can occur if two or more of the variables are correlated in the regression model.  Field 
(2009) points out that low levels of correlation are common, but strong correlations can 
lead to difficulties in assessing contribution of predictor variables, limit size of R, and 
increase standard errors of b coefficients.   
A multiple regression analysis was planned to see if the moderator variables of 
age, education, ethnicity, and income have an effect on the relationship between 
physician-patient relationship and patient treatment adherence.  According to Hayes 





moderator variables may have on the relationship between the independent and 
dependent variable.  Moderator variables may affect direction, strength, or the 
relationship between the independent and dependent variable (Baron & Kenny, 1986). 
Research Questions 1-5 were answered by using the results from the CAHPS 
survey which included patient satisfaction measures and demographics.  The DSMQ 
results, which is the outcome variable, were analyzed to determine patient treatment 
adherence, stratified into diet, exercise, and medication adherence.  The DSMQ also 
included response boxes where the participants could check that a measurement was not 
part of their treatment (Schmitt et al., 2013).  For example, a participant may have been 






Threats to Validity 
  Threats to both internal and external validity can occur.  The participants who 
complete the survey might decide not to be factual or not complete the survey.  They may 
not feel comfortable giving more negative scores as responses to questions about their 
healthcare provider, or the provider’s office staff.  It may be difficult to recruit a diverse 
group of participants, as only a small percentage of people participate in research.  This 
percentage is even lower in minority groups (Moyer, 2009). 
Another threat to validity is multiple submissions online.  These can be prevented 
because SurveyMonkey has software that has multiple responses turned off by default.  If 
someone tries to respond to the same survey again, they are prevented from doing so 
(SurveyMonkey, 2016a).  Since the participants remained anonymous, no participants 
were tracked by email address or IP address and no personal identifying information such 
as their name were collected.  
Since this study was based on a correlational design, one threat to the internal 
validity may be that the hypothesized correlation between the physician-patient 
relationship and medication adherence may be affected by other variables that moderate 
the relationship.  An external threat to validity may be that the results from the 
participants surveyed for this study will not be reproducible in other patient populations.  
However, providing the option to complete a paper survey helped to ensure participation 
by participants that did not have access to the internet.  In 2011, it was estimated that 





these individuals were more likely to be poorer, minority, low income, and or older.  It 
was important to capture some of these participants as well because of the survey 
questions and moderator variables. 
Ethical Issues 
 Ethical considerations for this study were addressed utilizing the American 
Psychological Association’s (2010) “Ethical principles of psychologists and code of 
conduct,” the Health Insurance Portability and Accountability Act of 1996 (HIPAA), and 
the Walden University’s Institutional Review Board (IRB) guidelines.  The American 
Psychological Association (APA) guidelines contain several ethical standards to follow 
when conducting research. These include the need for IRB approval, informed consent 
and release of data once published, if requested by other professionals, as long as 
confidentiality can be maintained.  Results from the CAHPS® Clinician and Group 
Survey, if not altered, can be uploaded and added to the growing database of research 
using these surveys, which is then made available to other researchers.  If this occurs, no 
identifying information of the participants would be included.  Additionally, other ethical 
considerations surrounding the informed consent by the participants, were that the 
informed consent include information about the research purpose, duration, procedures, 
potential benefits and risks of being a part of the research, confidentiality, rights, and the 
participant’s option to withdraw from the study even if the research has started (APA, 
2010).  Also included in the informed consent was contact information for the 
participants.  This contact information allowed them to contact Walden’s IRB, the 





Additionally, the informed consent included some resources to review from the websites 
of the American Diabetes Association and the Mayo Clinic for the patient to access if 
they required more support.   
The participants’ protected health information (PHI) and personal identifying 
information were not collected.  This ensured participant privacy.  The HIPAA Privacy 
Rule states that PHI created or maintained by covered entities like hospitals or health care 
plans cannot be released without certain conditions being met.  Even a researcher who is 
not part of the covered entity may have to abide by the Privacy Rule if he or she collects 
data from a covered entity (National Institutes of Health, 2007).  Some of the surveys 
collected for this study may come from covered entities like healthcare clinics.  No 
participants were harmed by participating in this survey and no follow-up with the 
participants occurred. 
The computer used during the data collection process and analysis was password-
protected and only the researcher had the password.  Data collected was and will be kept 
secure in a fire proof safe.  No identifying patient information was collected in this 
process and each of the completed surveys was assigned a unique code for SPSS input.  
Summary 
This chapter included information on the study design, rationale for conducting 
the study, inclusion criteria for participant recruitment, instruments and data analysis.  
The data analysis was conducted to see if there was a correlation between scores on the 
survey and medication adherence, as measured by changes in DSMQ scores, while 





included were the research questions, ethical considerations and potential threats to 








Chapter 4: Results 
Introduction 
The purpose of this quantitative study was to examine the relationship between 
the level of patient satisfaction with their healthcare provider and treatment adherence 
among a sample of patients with T2DM.  Also examined were the potential moderating 
effects of age, education, ethnicity, and income.  Data were obtained from participant 
responses on two surveys.  Responses on questions from the CAHPS survey provided 
data on the physician-patient relationship and the moderator variables.  Responses on the 
DSMQ provided data on treatment adherence with T2DM.  Participants completed these 
surveys either online through SurveyMonkey or Survata or through paper-and-pencil 
surveys at designated medical offices.  Data were analyzed using SPSS 24 software to 
answer the following research questions: 
RQ1: Among patients (ages 18+) with T2DM, is there a significant relationship 
between treatment adherence as measured by scores on the DSMQ, and the patients’ 
scores on physician-patient satisfaction surveys for patients with T2DM?  
H01: Among patients (ages 18+) with T2DM, there is no significant relationship 
between scores on the DSMQ and scores on physician-patient satisfaction surveys. 
HA1: Among patients (ages 18+) with T2DM, there is a significant relationship 






RQ2:  Does age moderate the relationship between patient satisfaction scores and 
treatment adherence? 
H02: There is no moderating effect of age on the relationship between patient 
satisfaction and treatment adherence. 
HA2: There is a moderating effect of age on the relationship between patient 
satisfaction and treatment adherence. 
RQ3: Does level of education moderate the relationship between patient 
satisfaction and treatment adherence? 
H03: There is no moderating effect of level of education on the relationship 
between patient satisfaction and treatment adherence. 
HA3: There is a moderating effect of level of education on the relationship 
between patient satisfaction and treatment adherence. 
RQ4: Does ethnicity moderate the relationship between patient satisfaction and 
treatment adherence? 
H04: There is no moderating effect of ethnicity on the relationship between 
patient satisfaction and treatment adherence. 
HA4: There is a moderating effect of ethnicity on the relationship between patient 
satisfaction and treatment adherence. 
RQ5: Does income moderate the relationship between patient satisfaction and 
treatment adherence? 
H05: There is no moderating effect of income on the relationship between patient 





HA5: There is a moderating effect of income on the relationship between patient 
satisfaction and treatment adherence. 
Statistical tests using correlational and multiple regression analyses were used to 
test the hypotheses.  In this chapter, data collection will be discussed, along with 
participant demographics, quantitative analyses, and interpretations of the data. 
Data Collection 
 There were 92 participants, of which 80 were online and 12 completed paper-and-
pencil surveys.  Data for this study were initially collected using either the 
SurveyMonkey platform or paper surveys.  Participants were recruited from Facebook, 
Nextdoor, the TPA, and the Walden University’s participant pool.  The Louisiana clinic 
participants were  provided with paper surveys and flyers so that the participants could 
choose to fill out a paper or online survey.  There were 10 participants from this clinic.  
After several weeks, the study accrual of participant responses fell short of what was 
required and the decision was made to work with another online survey company, 
Survata as well as, another clinic located in Texas.  This clinic had two participants that 
filled out surveys.  With these additional sources, I was able to recruit the additional 
participants needed for the study, with a significant portion of the surveys coming from 
Survata (n = 71).   
 Both the online and paper surveys included an informed consent form.  Online 
participants clicked on a link provided by the researcher.  Paper surveys were placed in 
self-addressed stamped envelopes along with the informed consent form.  To qualify for 





least a year, and seen their physician at least once in the previous year.  A total of 92 
participants were needed for the study.  SurveyMonkey surveys were downloaded 
directly into SPSS version 24.  Survata surveys were downloaded into Microsoft Excel 
and then transferred to SPSS.  Paper surveys were transcribed manually into SPSS by the 
researcher.   
Demographic Characteristics 
 There were 92 responses, which was the minimum amount of responses needed 
for the study according to the power estimation reported in Chapter 3.  The sample 
consisted of 55 (59.8%) females and 37 (40.2%) males (see Table 1).  The age range of 
the participants was 23-81 years of age.  The racial distribution of this sample was not a 
true representation of the United States population.  Most of the study participants were 
White, 80.4% versus the 2016 U. S. Census estimate of 61% (USBC, 2017).   
 A large percentage of the participants had attended some college, graduated, or 
had post-graduate training.  Almost 60% of the participants reported incomes of $50,000 
per year or higher. Regarding how long the participants had been seeing their physician, 
approximately 65% of the participants reported seeing the same physician for three to 
five years or more.  Finally, a question was asked about other individuals who were 
involved in the participants’ treatment for T2DM.  Only three participants reported that 











Demographic Characteristics of the Study Participants (N= 92) 




     Male 








     18-29 
     30-44 
     45-59 
     60-74 












  3.3 
Race 
    White 
    Black or African American 
    Asian 
    Native Hawaiian or Other Pacific  
    Islander 
    American Indian or Alaskan 
Native 












  8.7 
  4.3 
 
  0.0 
 
  3.3 
  3.3 
Ethnicity 
     Hispanic 
     Non-Hispanic 








  5.4 
Education Level 
      8th grade or less 
      Some high school, but did not   
      graduate 
      High school graduate or GED 
      Some college or 2-year degree 
      4-year college graduate 
      More than 4-year college degree 

















    <$24,999 
    $25,000-$49,999 
    $50,000-$99,000 















    Prefer not to answer   
Table 1 Demographic Characteristics of the Study Participants (N= 92) 
(continued) 
 
Length of time seeing the physician 
    Less than 6 months 
    At least 6 months but less than 1 
year 
    At least 1 year but less than 3 years 
    At least 3 years but less than 5 
years 









   
  6.5 
19.6 




Number of visits previous 12 months 
    1 time 
    2 times 
    3 times 
    4 times 
    5 to 9 times 













  8.7 
  2.2 
Other Individuals Involved in T2DM 
Management                       







Other Medical Staff 























 Questions from the CAHPS as well as questions from the CAHPS 
Supplemental Items were used to capture information about the physician-patient 
relationship and demographic information.  The DSMQ (Appendix A) was used to 






 Analysis testing was conducted for reliability and internal consistency of the 
CAHPS and the DSMQ with Cronbach’s coefficient alpha.  Cronbach’s alpha coefficient 
is a measure of the reliability of a test.  According to Cronbach (1951), if a test has 
factors that can be added into subscales then these composite scales should be analyzed 
too.  Many sources report that a Cronbach’s alpha coefficient of .7 or .8 is considered 
acceptable, but sometimes the diversity of the constructs can lead to lower values that are 
still within an acceptable range (Field, 2009).  
The Cronbach’s alpha coefficient for the CAHPS survey was (.88).  The 
Cronbach’s alpha coefficient for the DSMQ was (.78).  This is in line with a study by 
Schmitt et al. (2013) on the development of the DSMQ, overall (α =.84), with the 
subscales varying from α =.77 to α =.60. 
Skewness and kurtosis scores are used to determine normality of the distribution  
A skewness score of 0 is ideal, but scores can vary from -1 to +1 and still be acceptable 
(George & Mallery, 2016).  Skewness is a measure of the symmetry of the scores, while 
kurtosis is a measure of shape of the distribution (Field, 2009).  Kurtosis scores from -2 
to +2 are still considered acceptable (George & Mallery, 2016).  Tests for the skewness 
and kurtosis of the patients’ level of satisfaction with the provider scores (CAHPS) and 
the patients’ T2DM treatment adherence scores (DSMQ) were run. The assumption of 







Mean, Standard Deviation, Range, Skewness, and Kurtosis for Study Measures (N=92) 





CAHPS 8.42 1.10 4.28-9.75   0-10    -1.26    1.40 
 
DSMQ 7.56 1.53 3.30-10.0   0-10    -.670    -.682 
 
  
Linear regression statistics were run to assess for multicollinearity of the 
variables, including the dependent, independent, and moderator variables.  
Multicollinearity can occur when the relationship between two variables are too closely 
linear related.  The variance inflation factor (VIF) is used as a measure of 
multicollinearity (Field, 2009). SPSS was used to measure multicollinearity.  Each of the 
variables was placed in the dependent variable box, one a time, DSMQ, CAHPS, age, 
education, ethnicity, and income, while the others were placed in the independent 
variable box and compared.  The VIF range was from 1.0 to 1.4.  These numbers are 
acceptable and do not indicate that there are any concerns with multicollinearity for the 
study variables.  A VIF of 10 or more is considered high and a concern, as well as a 
tolerance of .2 or lower can be of concern (Fields, 2009). 
 According to Hayes’s (2013) regression-based approach, the assumption of 
homoscedasticity refers to the predictor variable values all having the same variance 
around the regression line.  To test for homoscedasticity, scatter plots were created and 





boxplots were conducted on the independent and dependent variables. Outliers are scores 
that differ from the rest of the scores.  Outliers can distort the data and bias the model 
(Field, 2009). There was one outlier in the independent variable group.  After examining 
the interquartile ranges, using descriptive statistics in SPSS, the outlier was determined to 
be a mild outlier.  A regression analysis was conducted with and without the outlier value 
and it was determined that there was a negligible effect on significance and therefore it 





Study Results  
Alternative Hypothesis 1  
The first alternative hypothesis was that there would be a significant relationship 
between treatment adherence (as measured by scores on the DSMQ) and the patient’s 
scores on the CAHPS for patients with T2DM.  A Pearson correlation two-tailed test of 
significance was conducted (alpha = .05).  The results indicated that the null hypothesis 
could be rejected because there was a significant correlation between the patients’ level 
of satisfaction with the provider and patient treatment adherence (r = .37, p < .001).  
Increased scores on the CAHPS were correlated with better T2DM treatment adherence.  
According to Cohen (1992), an R2 of .14 represents a medium effect size and a moderate 
correlation, while a p value of p < .001 signifies that this relationship is statistically 
significant.  
 The CAHPS survey can also be stratified into composite scores as indicated in 
Chapter 3.  Two composite scores were examined, 1) how well the providers 
communicated with the patient, and 2) providers are polite and considerate.  A Pearson 
correlation two-tailed test of significance was conducted to analyze both of the composite 
scores.  There were significant correlations found between how well the provider 
communicated with the patient and their treatment adherence (r = .32, p = .002), and how 
polite and considerate the provider was and patient treatment adherence (r = .28, p = 







DSMQ, CAHPS and CAHPS Composite Scores: Correlations and Descriptive Statistics 
(N = 92) 






































Variables 1 2 3 4 
M 
 
SD               




          8.4 
 
        1.10 
 
 
        8.7 
 
       1.43             
        8.8 
 
 1.50 
               
 * p < .05 **p < .01 ***p < .001 
 
Alternative Hypotheses 2-5 
Variables that can affect the relationship between two other variables are known 
as moderators.  To estimate this, an interaction term (CAHPS x moderator) is added to 
the regression model (Laerd, 2013; see Figure 1).  Alternative hypotheses 2-5 included 
the moderating variables of age, education, income, and race.  Hayes’s (2013) macro 
PROCESS version 2.16.3 was used to assess moderation.  The macro PROCESS is based 





the assumption is made that the variables are continuous, fixed effects, and no random 
measurement error (Hayes, 2013). 
 
        
                                      
                                     b1              
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Figure 1. PROCESS Model 1 conceptual and statistical diagram. Source: Hayes (2013).  
 
Alternative Hypothesis 2  
The second alternative hypothesis was that age would moderate the relationship 
between treatment adherence and the patient’s scores on physician-patient satisfaction 
surveys for patients with T2DM.   
Age. To test the hypothesis that age moderates the relationship between the level 
of patients’ satisfaction with their provider and their T2DM treatment adherence, a 
regression was conducted using PROCESS.  The variable “age” was entered as a 









dependent variable (DSMQ) scores were entered, using Model 1 in PROCESS.  The 
overall model was statistically significant, R2 = .146, F (3, 88) = 6.02, p = .001.  
However, the interaction between the CAHPS scores and age was not statistically 
significant, (b = -.009, t(92) = -.675, p = .50).  These results suggest that age does not 
moderate the relationship between level of patients’ satisfaction with their provider and 
their T2DM treatment adherence.  Therefore, the null hypothesis cannot be rejected.  A 
summary of the findings is depicted in Figure 2. 
       
  
                                      
                                     b1 = .410(p= .02)           
     
                                     b2 = .011 (p= .38) 
                                                                         
                                    b3 = -.009(p= .50) 




Figure 2. Model of physician-patient relationship and patient treatment adherence  
moderated by age 
 
Alternative Hypothesis 3 
The third alternative hypothesis was that education would moderate the 
relationship between treatment adherence and the patient’s scores on physician-patient 
satisfaction surveys for patients with T2DM.  
Education. To test the hypothesis that education moderates the relationship 
between the level of patients’ satisfaction with their provider and their T2DM treatment 
adherence, a regression was conducted using PROCESS.  The variable “education” was 
Predictor 
(CAHPS) 
      Moderator 
Moderator 
(Age) 
     Predictor  
          X 







entered as a continuous variable, the independent variable (CAHPS) scores were entered, 
and the dependent variable (DSMQ) scores were entered, using Model 1 in PROCESS.  
The overall model was statistically significant, R2 (.142), F (3, 88) = 5.12, p = .003.  
However, the interaction between the CAHPS scores and education was not statistically 
significant, (b = .022, t (92) = .176, p = .86).  These results indicate that education does 
not moderate the relationship between level of patients’ satisfaction with their provider 
and their T2DM treatment adherence.  Therefore, the null hypothesis cannot be rejected.  
Please see Figure 3 for a summary of these findings. 
 
                                      
                                    b1 = .530 (p= <.001)         
  
                                     b2 = -.120 (p= .50) 
                                                                         
                                    b3 = .022 (p= .86) 
                                      
 
 
Figure 3. Model of physician-patient relationship and patient treatment adherence  
moderated by education. 
 
Alternative Hypothesis 4 
The fourth alternative hypothesis was that ethnicity would moderate the 
relationship between treatment adherence and the patient’s scores on physician-patient 
satisfaction surveys for patients with T2DM  
Ethnicity. To test the hypothesis that ethnicity moderates the relationship 
between the level of patients’ satisfaction with their provider and their T2DM treatment 
adherence, a regression was conducted using PROCESS.  The variable “ethnicity” was 
Predictor 
CAHPS 
     Moderator   
    (Education) 
     Predictor  
           X 







entered as a continuous variable, the independent variable (CAHPS) scores were entered, 
and the dependent variable (DSMQ) scores were entered, using Model 1 in PROCESS.  
The overall model was statistically significant, R2 (.155), F (3, 88) = 6.77, p < .001.  
However, the interaction between the CAHPS scores and ethnicity was not statistically 
significant, (b =.141, t (92) = .001, p = .29).  These results indicate that ethnicity does not 
moderate the relationship between level of patients’ satisfaction with their provider and 
their T2DM treatment adherence.  Therefore, the null hypothesis cannot be rejected.  
Figure 4 depicts a summary of these findings. 
.     
                                      
                                    b1 = .531 (p <.001)          
  
                                     b2 = .088 (p= .49) 
                                                                         
                                    b3 = .141 (p=.29 
                                      
 
 
Figure 4. Model of physician-patient relationship and patient treatment adherence  
moderated by ethnicity   
 
Alternative Hypothesis 5 
The fifth alternative hypothesis was that income would moderate the relationship 
between treatment adherence and the patient’s scores on physician-patient satisfaction 
surveys for patients with T2DM  
Income. To test the hypothesis that income moderates the relationship between 
the level of patients’ satisfaction with their provider and their T2DM treatment 
adherence, a regression was conducted using PROCESS.  The variable “income” was 
Predictor 
(CAHPS) 
   Moderator 
   (Ethnicity) 
     Predictor  
           X 







entered as a continuous variable, the independent variable (CAHPS) scores were entered, 
and the dependent variable (DSMQ) scores were entered, using Model 1 in PROCESS.  
The overall model was statistically significant, R2 (.152), F (3, 88) = 7.80, p = .000.  
However, the interaction between the CAHPS scores and income was not statistically 
significant, (b = -.013, t (92) = -.097, p = .923).  These results suggest that income does 
not moderate the relationship between level of patients’ satisfaction with their provider 
and their T2DM treatment adherence.  Therefore, the null hypothesis cannot be rejected.  
Please see Figure 5 depicts a summary of these findings. 
 
                                      
                                     b1 = .510 (p= .51)           
  
                                     b2 = .180 (p=.18) 
                                                                         
                                      b3 =-.013 (p= .92)        
                             
                                       
 
Figure 5. Model of physician-patient relationship and patient treatment adherence  
moderated by income. 
 
Additional Analyses 
Examination of the data and the study findings suggested additional analyses.  
There were three variables from the CAHPS survey that were examined.  The first 
variable was about the length of time that the patient had visited the provider, from six 
months or less, to five years or more.  The second variable was the number of times that 
Predictor 
(CAHPS) 
    Moderator 
     (Income) 
     Predictor  
           X 







the patient had seen the provider in the past year, from one time to 10 or more times.  The 
third variable was gender. 
A Pearson correlation two-tailed test of significance was conducted on each of the 
variables and the DSMQ.  The results for length of time were statistically significant (r = 
.44, p = .04).  The result for the number of times was not statistically significant (r = .22, 
p = .27).  This suggests that number of visits is not correlated with patient’s T2DM 
treatment adherence, but the length of time that the patient had been a patient of the 
physician is correlated with T2DM treatment adherence. 
Gender, another variable from the CAHPS survey, was also examined to see if 
there was a moderating effect on treatment adherence.  To test the hypothesis that gender 
moderates the relationship between the level of patients’ satisfaction with their provider 
and their T2DM treatment adherence, a regression was conducted using Model 1 in 
PROCESS.  The variable “gender” was entered as a categorical variable, the independent 
variable (CAHPS) scores were entered, and the dependent variable (DSMQ) scores were 
entered, using Model 1 in PROCESS.  The overall model was statistically significant, R 
(.451), F (3, 88) = 6.83, p < .001.  The interaction between the CAHPS scores and gender 
was also statistically significant, (b =-.608, t(92) = -.2.26, p = .03).  These results suggest 
that gender does moderate the relationship between level of patients’ satisfaction with 
their provider and their T2DM treatment adherence.  A plot was generated from the 
results to evaluate gender, grouped by male and female.  Evaluating the plot lines, males 





versus females whose treatment adherence scores were not as affected as much by their 
CAHPS scores (see Figure 6).    
 
Figure 6. Interaction between the variable “gender” and the CAHPS and DSMQ scores.  
Note: 1= Male and 2 = Female. 
 
Summary 
A Pearson correlation was performed on the two main variables of the DSMQ 
dependent variable and the CAHPS independent variable.  The null hypothesis for 
research question one was rejected, as there was a significant correlation between the 





adherence.  Two CAHPS composite score variables were also analyzed individually, 
along with the DSMQ variable using Pearson correlations.  Significant correlations were 
found for both composite score variables.   
Research questions 2-5 included the moderating effects of age, education, income, 
and race in the relationship between CAHPS and DSMQ.  There were no significant 
interactions for any of the moderators; therefore, the null hypotheses were not rejected for 
age, education, ethnicity, or income.    
Secondary exploratory analyses were conducted to see if the length of time that 
the subject had been a patient of the provider and number of times the patient was seen 
by the provider in the past year correlated with treatment adherence.  The results show 
that only the length of the time that the subject had been a patient of the provider was 
statistically significant.  Gender was also examined to see if it had a moderating effect on 
treatment adherence.  The null hypothesis was rejected as gender had a moderating effect 
on the physician-patient relationship and patient’s treatment adherence.   
In Chapter 5, the present study is summarized, along with the purpose and the 
nature of the study.  Key findings are described, interpreted, and compared to findings in 
the Chapter 2 literature review.  Limitations, reliability, and validity of the study are 






Chapter 5: Discussion  
Introduction 
Diabetes is a growing and costly chronic disease.  Despite improvements in 
medications, technology, and other adherence methods, adherence for T2DM still hovers 
around 50% (García-Pérez et al., 2013).  Diet and exercise are also recommended as part 
of T2DM management, but patients do not always follow these recommendations 
(García-Pérez et al., 2013), even though diet, exercise, and medication adherence 
improve T2DM outcomes (Vasilescu, 2015).  The ADA recommended individualizing 
treatment for patients by using shared-decision making between the physician and patient 
and also understanding the patient’s background (Romeo & Abrahamson, 2015).  While 
there are provider, patient, and system factors that affect patient adherence, this study was 
designed to focus on provider factors.  
The purpose of this quantitative correlational study was to investigate the 
physician-patient relationship and T2DM treatment adherence.  Also evaluated were 
moderator variables of age, education, ethnicity, and income.  These were included to see 
if these variables moderated the relationship between the physician-patient relationship 
and treatment adherence.  Secondary analyses were also conducted on two composite 
scores from the CAHPS survey (provider communication and politeness), length of time 
the participant had been a patient of the physician, how many times the participant had 
seen the physician in the previous 12 months, and gender.  There were five research 
questions in this study.  Research question one (RQ1) was used to determine if the patient 





adherence.  Research questions 2-5 examined if the variables of age, education, ethnicity, 
and income moderated this relationship.  The results were significant for the RQ1.  None 
of the moderator variables were significant for moderating the relationship, but a 
secondary analysis evaluating gender as a moderator was significant.  
Interpretation of the Findings 
Hypothesis 1   
Hypothesis 1 was supported by the data.  Higher scores on the CAHPS survey 
were correlated with better patient treatment adherence.  This is in line with other studies 
that have been conducted to evaluate the physician-patient relationship, physician-patient 
engagement, and shared-decision making.  The findings show that better communication, 
shared-decision making, and physician engagement leads to better patient treatment 
adherence.   
 Many of the studies that were designed to evaluate the physician-patient 
relationship incorporate only one aspect of the relationship, for example trust.  This 
current study included  questions that captured many different elements of the physician-
patient relationship.  These included questions about trust, respect, listening, feeling 
respected, understanding what was being communicated by the physician, education 
about the patient’s diabetes, whether the physician interrupted or ignored the patient, and 
concern and caring for the patient.  
Communication needs to go both ways.  The patient cannot just answer questions 
asked by the physician; the patient needs to participate, ask questions, and let the 





the physician to have a better understanding of the patient in a more holistic way and 
reduces physician stereotyping or judging of the patient.  Bundesmann and Kaplowitz 
(2011) found that effective physician communication about diabetes treatment led to 
better patient self-care.  Ratanawongsa et al. (2013) reported that higher scores on a 
patient survey on provider communication led to higher medication adherence for 
patients who were dispensed diabetes, antihypertensive, or lipid lowering medications, 
while lower provider scores were equated with lower medication adherence.  More 
engaged patients have better health outcomes, including those with diabetes (Simmons, et 
al., 2014).  Polonsky et al. (2017) found that physicians who were collaborative and 
encouraging reported that this might lead to better patient T2DM self-management and 
treatment adherence.  When the health beliefs of the physician and the patient are in 
alignment, improved medication adherence is seen (Christensen et al., 2010).  The 
opposite holds true too.  When there is a lack of clear communication, medication 
adherence can decrease, especially when the physician gives only basic information to 
the patient, while the patient desires more comprehensive education about their disease 
and how to manage it properly (Lapane, Dube, Schneider, & Quilliam, 2007).  Other 
factors that can decrease medication adherence include the physician focusing on the 
biomedical aspects of the disease instead of the sociodemographic factors that the patient 
may be facing and lack of information about his or her medication regimens 
(Schoenthaler, Knafl, Fiscella, & Ogedegbe, 2017).  Patients find less value in 
medication reminders like texts and more value in receiving education about dosing and 





The CAHPS survey used in the present study includes two composite score 
subscales, one on how well the provider communicated and one on how respectful the 
provider was with the patient.  Analyses using Pearson correlation two-tailed test of 
significance were conducted (alpha = .05) on these two composite score subscales.  Both 
were also statistically significant for treatment adherence.  Two other variables from the 
CAHPS were evaluated.  One was the length of time that the participant had been a 
patient of the physician and number of times that the patient had seen the provider in the 
past 12 months.  The length of the relationship was significantly correlated with treatment 
adherence.  Increased time, meaning how long the participant had been a patient of the 
physician, was correlated with better treatment adherence.  In Cotugno et al.’s (2015) 
study, patients reported that they highly valued a productive and continued relationship 
with their healthcare provider.  This continuity of care was important to these patients.   
A longer established relationship with the physician can be interpreted as both the 
physician and patient working well with each other.  As for number of times the patient 
saw the physician not being a significant finding, this was difficult to predict.  If a patient 
was seeing his or her physician more frequently, it may have been because of a lack of 
treatment adherence or better treatment adherence.  For example, the patient may have a 
more complicated case of T2DM requiring diet, exercise, and medication requiring more 
interaction with his or her physician.  The patient might also have trouble controlling his 
or her T2DM, which made it necessary to see his or her physician more to gain better 
control over their disease.  Likewise, a patient may have been seen less frequently either 





appointments.  In the current study, some of the patients were not on medications and 
were not required to measure their blood glucose levels.  The National Institute for 
Health and Care Excellence’s (2018) guidance study on Type 2 diabetes in adults 
reported that self-monitoring of glucose is not recommended unless the patient is on 
insulin, has had hypoglycemic episodes, is on oral medications that could increase his or 
her risk while driving or operating equipment, or is pregnant or considering becoming 
pregnant. (National institute for Health and Care Excellence, 2018).   
If their disease was easily managed, the patients would not have to see their 
physician as frequently.  However, some of the patients may have skipped appointments, 
even though their diabetes was not being well controlled.  Also, another factor is that 
other clinic staff may have helped the patients manage their diabetes treatment.  For 
example, the patient may have been seeing an advanced practitioner, such as a nurse with 
more specialized training instead of the physician for certain appointments during the 
previous year.  This would have skewed the results also.  In summary, it is hard to 
determine why exactly a patient would have seen his or her physician more or less times 
during the previous year. 
The significance of the physician-patient relationship cannot be underestimated.  
This relationship is the foundation for what happens next for patient treatment adherence 
and it starts with a conversation.  Patients who feel heard and trust their physicians are 
more likely to discuss barriers to their treatment adherence.  It is during this conversation 
that the physicians are able to truly understand what potential challenges the patients may 





plan to their patients and include the patients in their treatment decisions, thereby 
empowering the patient to self-manage.  Even the ADA recommends an individualized 
treatment approach for patients diagnosed with diabetes, including shared decision-
making.  This includes an understanding by the physician on the patient’s cultural 
background, comorbidities, preferences, and likelihood of medication adherence (Romeo, 
& Abrahamson, 2015), along with viewing the patient through a biopsychosocial lens, 
instead of the strictly biomedical model.  It is important to listen to the patient and his or 
her self-reported information as opposed to standardized treatment (Schunk, Stark, 
Reitmeir, Meisinger, & Holle, 2015).   
Hypotheses 2-5 
   Hypotheses 2-5 were included to address whether the moderator variables of 
age, education, ethnicity, and income individually acted as moderators between the 
physician-patient relationship and the patient’s treatment adherence.  None of these 
moderators were found to be significant for moderating this relationship.  However, a 
secondary analysis using gender as a moderator between the physician-patient 
relationship and patient treatment adherence was statistically significant.   
 Age.  The second hypothesis, age was not found to be a significant moderator of 
the physician-patient relationship and patient treatment adherence.  There is limited 
information on how age modifies the relationship between the physician-patient 
relationship and treatment adherence.  One study by Peck (2011) had results that older 
patients had better patient-centered encounters, but another study by Smith (2013) had 





gathered data from a geriatric clinic, while Smith (2013) gathered data from a national 
survey that included a subset of communities.  Younger patients may view the physician 
as an authority figure.  All age groups were well represented in this current study. 
 Education. The third hypothesis, education was not found to be a significant 
moderator of the physician-patient relationship and patient treatment adherence.  This is 
in contrast to what has been reported in other studies.  Higher education has been 
associated with better quality diets (Darmon & Drewnowski, 2008; Kell et al., 2015), and 
found more likely to relate to exercise (Morrato et al., 2007).  One aspect of education is 
health literacy, which can also moderate this relationship.  Approximately one-third of 
patients are thought to have basic or low health literacy (Weiss, 2015).  Patients with low 
health literacy may not feel comfortable asking questions of their providers (Verlinde et 
al., 2012), and they may not be adherent to their medication because they do not 
understand T2DM and the importance of adherence (Koprulu et al., 2014).  One reason 
why the moderator for education was not significant may be the participant population.  
The participants in this current study were more educated than average with almost 97% 
having two years of college or more, while only 2.2% had only a high school education.   
 Ethnicity.  The fourth hypothesis, ethnicity was not found to be a significant 
moderator of the physician-patient relationship and patient treatment adherence.  The 
patient population in this study was not racially or ethnically diverse.  Approximately 
80% identified as White.  A more diverse population may have resulted in ethnicity being 
a significant moderator.  However, other studies have different results.  Ethnicity has 





approach all patients the same way despite the patient’s cultural background (Mott-Coles, 
2014).  Stereotyping of patients also occurs leading to miscommunication and less ideal 
health outcomes (King et al., 2008).  Johnson, Roter, Powe, and Cooper (2004) found that 
physicians communicated less with African American patients and dominated the 
conversations more than with White patients.  Treatment adherence stratified by race is 
not well researched (Peeters et al., 2011).  Patients from different ethnic backgrounds 
may have difficulty switching their diets toward food choices that do not match their 
customary, culturally specific one (Cheng et al., 2016) and may not understand what 
healthy food choices are versus, what they are not (Carr, 2012).  Food insecurity can also 
affect diet even if the patient wants to eat healthy (Strings et al., 2016).  Diet 
recommendations are often not tailored to the ethnic background of the patient.   
 Income.  The fifth hypothesis, income was not found to be a significant 
moderator of the physician-patient relationship and patient treatment adherence.  This 
differs from other studies where results show  that physicians can act differently towards 
patients with lower-income levels by not spending enough time with them or not 
explaining things so that the patient is able to understand the information.  Physicians are 
also less likely to participate in shared decision-making with patients from lower SES 
backgrounds (Verlinde et al., 2012).  Trust can also be affected. Patients who feel more 
socially distant may lack trust in their physicians, and the physicians may not trust that 
the patient will adhere to medication regimens.  Poverty can cause individuals to not seek 
medical care and be treated negatively by the physician (Loignon et al., 2010).  Culture 





(2010) discussed that a cultural belief held by some of the Indian elders was that care for 
diabetes symptoms should only be sought when symptoms became serious, due to a 
distrust of the White medical establishment. 
Income can affect where a patient resides, the safety of his or her neighborhood, 
and even the patient’s medication beliefs (Billimek & August, 2014).  The nonsignificant 
results from this study are surprising since different income levels in this study were well 
represented.  In spite of this, Billimek and August (2014) reported that education, gender, 
ethnicity, and SES factors did not have an impact on physician communication and 
patient self-care behaviors for patients diagnosed with T2DM.   
Interpretation of Results Guided by Theories 
Guiding the direction of this study were the biopsychosocial (BPS) model and the 
self-efficacy theory.  BPS relates to how treatment adherence is not just based on the 
medical aspect of diabetes treatment.  Psychological and social factors also impact 
disease.  For example, a patient may want to exercise to manage his or her diabetes but 
live in an area where he or she feels unsafe walking around.  If the physician is not aware 
of this issue, he or she may feel that the patient is choosing not to listen to his or her 
recommendations, which may affect the physician-patient relationship.  The 
psychological aspect of the BPS is also an important part of treatment adherence.  
Patient’s beliefs about their diabetes can also impact treatment adherence.  The patient 
may not be motivated to manage his or her diabetes or feel stressed about it.  





Trust in the physician helps reduce emotional distress for the patient and this leads to 
better self-care activities by the patient (Niazi & Rafique, 2017). 
It is important that the physician build a “working alliance” with the patient.  Due 
to managed care, physicians now have less time with patients.  Building a working 
alliance does not mean spending more time with the patient, rather it is important to 
improve the quality of the visit.  A working alliance incorporates shared-decision making 
and goal setting, therefore, it is also important for the physician to understand that 
without the cooperation of the patient, the physician will be unable to improve the 
patient’s outcomes (Fuertes, Toporovsky, Reyes, & Osborne, 2017).  This is much more 
reflective of the BPS than the medical model. 
Montori (2017) discussed the burden of treatment for patients.  Patients have to 
manage their treatment, whether it is coordinating their own care and appointments, or 
managing their disease, while still juggling other life tasks.  Patients may feel that they 
cannot manage their disease and life in general leading to a shortfall where patients are 
nonadherent.  This can cause both the patient and the physician to feel frustrated.  
Another aspect of diabetes treatment management is related to the theory of self-
efficacy.  Unlike the BPS theory, which is used to address the factors that affect the 
patient’s health, the theory of self-efficacy involves the patient and how he or she learns 
to control his or her diabetes (Lorig & Holman, 2003).  Self-efficacy comes from four 
sources: individual accomplishment, verbal persuasion, physiological state, and vicarious 
experience through others (Bandura, 1977).  Chronic disease is unlike acute disease in 





self-management involves managing the disease, living a meaningful life while coping 
with the chronic disease, and emotionally adjusting to the disease.  Part of managing 
chronic disease, along with medical knowledge, is helping the patient connect with other 
patients so that these other patients can share their patient knowledge about effectively 
managing their disease.   
Three assumptions of peer-led chronic disease workshops are that the tasks and 
management of the chronic disease are similar, people can learn how to manage their 
disease more effectively, and this can lead to better health outcomes (Lorig, Ritter, Ory, 
& Whitelaw, 2013).  In this current study, patients were not asked if they were a part of 
any support group to help manage their T2DM, although they were asked if there were 
other individuals in the physician’s office that helped them manage their T2DM.   
In summary, these findings add to the growing body of literature that effective 
management of T2DM requires a good working alliance between the physician and 
patient that is based on shared-decision making, respect and trust.  It also requires treating 
the patient in a holistic manner, taking into account the psychosocial factors that can 
impact the patient when trying to manage his or her T2DM.  
Limitations of the Study 
 There were some limitations in this study.  A larger sample size may have 
resulted in different results for the moderators, which typically require a large sample size 
for power.  However, even with the current study sample size, an effect size of .14 was 
calculated for the analyses, which is considered a medium effect size (Cohen, 1992).  





if a good relationship with one’s healthcare provider causes a change in patient treatment 
adherence, quality of the patient relationship with his or her provider did predict patient 
treatment adherence.  Other staff in the office that assisted the patient in managing the 
disease may also have had an impact on the study results, since only three of the patients 
reported that no one else in the office helped them manage their disease. 
A further limitation is that a significant proportion (80%) of the participants were 
White and with relatively high levels of education; therefore, these results cannot be 
generalized to other races or educational levels.  A requirement that the participants be 
fluent in English limited the participant sample, thus these findings cannot be generalized 
to individuals that are not fluent in English.  The sample population in this study does not 
mirror the general population.  There are non-English-speaking patients in the United 
States who have been diagnosed with T2DM and this language barrier may contribute to 
the kind of relationship that the patient has with the physician.  Communication may also 
be difficult between the physician and patient.  Also, the majority of participants in this 
study had a high school education or higher, many with two years of college or more.  
These participants are less likely to have been challenged by low health literacy.  Patients 
with low health literacy are estimated to comprise about one-third of the population 
(Weiss, 2015).  This can make it difficult for the patient to understand his or her disease 
and why he or she needs to be adherent (HHS, 2008). 
Additionally, the participants that filled out paper surveys were a smaller 





one in Louisiana and one in Texas.  Therefore, these results cannot be generalized to 
other clinics or other parts of the country. 
 This was also a self-report study and therefore the researcher could not verify if 
the participants were answering truthfully.  This study was also limited because the 
participants were asked only about the previous 12 months of experience with their 
provider, which would not capture their relationship changes over a longer period of 
time.  Finally, another limitation with asking about the previous 12 months might be 
problems with retrospective recall.   
Recommendations 
 One recommendation would be to conduct this study with a larger sample of 
participants.  The minimum number calculated was (n=92), and this was the number of 
participants in this study.  A larger number of participants that are more ethnically 
diverse may lead to more confidence with the moderation analyses.  Another 
recommendation would be to conduct a qualitative study using the same patient criteria 
used for this quantitative study.  It would be useful to interview patients being treated for 
T2DM to find out what factors in the physician-patient relationship the patient views as 
impacting his or her treatment adherence.  There may be other factors or factors that carry 
more weight in the treatment adherence.   
 A final recommendation would be to add more psychosocial variables to the 
survey.  For example, rather than asking just about exercise there could also be questions 
about barriers for the patient to exercise.  Recommending that a patient exercise, but not 





will not know whether the patient is choosing not to exercise, or instead lacks a safe place 
to exercise.  Another example is having the provider set up text message notifications for 
the patient to take his or her medications, which may not be helpful and may be at cross 
purposes if the patient cannot afford the medications and is afraid to let the physician 
know that he or she had not even filled their prescription.  However, good 
communications between the physician and patient may help the physician better 
understand any barriers that the patient might be facing, thereby leading to more 
workable solutions that help the patient better manage his or her disease. 
Implications 
 Current treatments for diabetes are not entirely successful.  About half of patients 
are not adherent to their treatment plan.  This places financial burdens on the patient, the 
healthcare system, and society as a whole.  The physician-patient relationship has been 
shown to affect patient treatment adherence.  
 The results for the main research question in this study were statistically 
significant.  Higher satisfaction with the physician-patient relationship was correlated 
with better patient treatment adherence in patients being treated for T2DM.  Patients who 
are engaged in their treatments are actively involved and understand what is needed to 
correctly manage their disease (Simmons, Wolever, Bechard, & Snyderman, 2014).  This 
is important because the incidence of diabetes and the healthcare costs associated with 
treating it and the other complications that can result from non-adherence continue to 
rise, along with obesity and an aging population.  When physicians fail to understand the 





background, they can miss barriers that impede patient treatment adherence.  This can 
lead to frustration for both the patient and physician.  Understanding the “whole” patient 
may lead to better patient treatment adherence, better patient quality of life, less diabetes 
complications and reduced healthcare costs.     
The lack of statistical significance for the moderators may indicate that the focus 
should be more on the physician-patient relationship.  Montori (2017) discussed how 
patient conversations could help to solve the problems that patients bring in to these 
meetings.  Additionally, this can lead to better health policies targeted to the true health 
requirements of the communities and inclusiveness for all patients.   
It is not enough to diagnose a patient with T2DM and then give him or her a 
treatment plan.  The provider needs to delve further into the patient’s background, and  
current lifestyle behaviors, to view the patient through a biopsychosocial lens in order to 
ensure the best outcome.  Montori (2017) discussed this approach for a patient named 
Maria Luisa who was the grandmother of one of his students.  Maria Luisa was from 
Peru, had chronic health conditions, necessitating a complicated pill regimen, underwent 
dialysis three mornings a week and was afraid of falling down the stairs in the house that 
she lived with her son and two daughters.  She was exhausted from her morning dialysis 
regimen, so she stopped doing her hobby, which was crocheting. The student, Ana, 
knowing the roadblocks to her grandmother’s health made some changes, by having an 
elevator installed, providing a compartmentalized pill box, changing the dialysis to the 
afternoons, and requesting Peruvian food recipes from a dietician in Peru (Montori, 





enjoyed eating, started crocheting again, increased her social circle, moved with ease 
between floors in her house, and was compliant with her medications.  This all eased her 
burden of treatment, helped her to feel better physically, and helped her to feel 
empowered and a participating member in her treatment (Montori, 2017).  
Conclusion 
 This current research was conducted using a sample of participants who could 
read and write English, were 18 years-of-age or older, and were being treated for T2DM 
for at least one year.  Online surveys were offered to some participants.  Paper-and-pencil 
surveys were also offered to participants who were patients of two clinics, one in 
Louisiana and one in Texas.  The physician-patient relationship and potential correlation 
with patient treatment adherence were analyzed.  The moderators of age, education, 
ethnicity, and income were examined to see if they moderated the physician-patient 
relationship and patient treatment adherence.  Additional secondary analyses were 
conducted on two of the composite scores from the physician-patient relationship survey, 
as well as, two other variables from the survey.  Gender was also analyzed as a potential 
moderator of the predictor and outcome variables.    
 The data were analyzed using correlation and multiple regression.  The results for 
the main hypothesis were statistically significant, but the hypotheses for the moderators 
of age, education, ethnicity, and income were not statistically significant.  However, two 
composite scores from the CAHPS survey analyzed using PROCESS with gender 
analyzed as a moderator were found to be statistically significant.  Two other variables 





patient was a patient of the physician was statistically significant, while numbers of visits 
to the physician in one year, was not.  Recommendations include: increasing the number 
of study participants for a quantitative study, conducting a qualitative study to understand 
what physician factors that patients view as impacting their treatment adherence, and 
adding more psychosocial variables to the CAHPS survey  
The results of this study add to the growing body of literature that supports the 
importance of the physician-patient relationships in improving T2DM patients’ treatment 
adherence.  This study finds that patients who are knowledgeable about their disease, 
engaged in his or her treatment, is involved in shared-decision making, and can have an 
honest conversation with their physician about his or her treatment and barriers to 
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Appendix B: Dissertation Research Request 
 
Facebook, Nextdoor, Texas Psychological Association and Walden Participant Pool 
 
My name is Cindy Schmidt.  I am a doctoral student in Clinical Psychology at Walden 
University.  I am conducting research to see if there is a significant relationship between 
treatment adherence and the patients’ scores on physician-patient satisfaction surveys for 
patients (ages 18+) diagnosed with type 2 diabetes mellitus (T2DM).  There are two self-
report surveys.  One includes questions about your provider and demographic 
information and the other survey includes questions about your diabetes management.  
The time to complete both surveys is about 15 minutes.  To participate in this study you 
must be 18-years-of-age or older, having been diagnosed with T2DM for at least a year, 
and have seen your provider at least once in the past year for diabetes treatment.  If you 
would like to participate, please click on the link, SurveyMonkey: 
https://www.surveymonkey.com/r/G2WP65S 
 
https://www.surveymonkey.com/r/M3LK9SB 
 
 
 
